10-Q 1 hain-03312017x10q.htm 10-Q
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________________
FORM 10-Q
___________________________________________
(Mark One)

ý | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended March 31, 2017

¨ | Transition Report pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

for the transition period from to .
Commission File No. 0-22818
___________________________________________
THE HAIN CELESTIAL GROUP, INC.
(Exact name of registrant as specified in its charter)
___________________________________________

Delaware |  | 22-3240619
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)
1111 Marcus Avenue Lake Success, New York |  | 11042
(Address of principal executive offices) |  | (Zip Code)

Registrant’s telephone number, including area code: (516) 587-5000
___________________________________________

Table of Contents
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes ¨ No ý
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes ¨ No ý
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer | ý |  | Accelerated filer | ¨ |  |
Non-accelerated filer (Do not check if a smaller reporting company) | ¨ |  | Smaller reporting company | ¨ | Emerging growth company | ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).
Yes ¨ No ý
As of June 16, 2017, there were 103,697,237 shares outstanding of the registrant’s Common Stock, par value $.01 per share.

Table of Contents
THE HAIN CELESTIAL GROUP, INC.
Index

| Part I - Financial Information | Page
| Explanatory Note | 2
Item 1. | Financial Statements |
| Consolidated Balance Sheets - March 31, 2017 and June 30, 2016 | 4
| Consolidated Statements of Income - Three and nine months ended March 31, 2017 and 2016 | 5
| Consolidated Statements of Comprehensive Income (Loss) - Three and nine months ended March 31, 2017 and 2016 | 6
| Consolidated Statement of Stockholders’ Equity - Nine months ended March 31, 2017 | 7
| Consolidated Statements of Cash Flows - Nine months ended March 31, 2017 and 2016 | 8
| Notes to Consolidated Financial Statements | 9
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 30
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 47
Item 4. | Controls and Procedures | 47
| Part II - Other Information |
Items 3, 4 and 5 are not applicable |
Item 1. | Legal Proceedings | 49
Item 1A. | Risk Factors | 32
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 50
Item 6. | Exhibits | 50
Signatures |  | 51
Exhibit Index |  | 52

1

Table of Contents
EXPLANATORY NOTE
As used in this Quarterly Report on Form 10-Q, the terms the “Company”, “Hain Celestial”, “Hain”, “we”, “us” and “our” mean The Hain Celestial Group, Inc. and its subsidiaries.
As previously reported, we were unable to timely file our Annual Report on Form 10-K for our fiscal year ended June 30, 2016 (the “Form 10-K”) and our Quarterly Reports on Form 10-Q for the quarters ended September 30, 2016 (the “Q1 Form 10-Q”), December 31, 2016 (the “Q2 Form 10-Q”) and March 31, 2017 (the “Form 10-Q”). During the fourth quarter of fiscal 2016, the Company identified the practice of granting additional concessions to certain distributors in the United States and commenced an internal accounting review in order to (i) determine whether the revenue associated with those concessions was accounted for in the correct period and (ii) evaluate the Company’s internal control over financial reporting. The Audit Committee of the Company’s Board of Directors separately conducted an independent review of these matters and retained independent counsel to assist in their review. We delayed the filing of this Form 10-Q and our Form 10-K, Q1 Form 10-Q and Q2 Form 10-Q with the Securities and Exchange Commission (the “SEC”) in order to complete these reviews.
Completion of Reviews. On November 16, 2016, the Company announced the completion of the independent review conducted by the Audit Committee, which found no evidence of intentional wrongdoing in connection with the preparation of the Company’s financial statements. The Company also disclosed that it would not be in a position to release financial results until the completion of its internal accounting review and the audit process. We are now filing this Form 10-Q as a result of the completion of the aforementioned reviews. Concurrent with the filing of this Form 10-Q, we are also filing our Form 10-K, Q1 Form 10-Q and Q2 Form 10-Q (collectively, our “Periodic Reports”). The Periodic Reports incorporate the findings from the aforementioned reviews, and address the remediation of the immaterial errors and identified material weaknesses in our internal control over financial reporting that existed at June 30, 2016, September 30, 2016, December 31, 2016 and March 31, 2017. These material weaknesses, as well as the Company’s remediation of such material weaknesses, are discussed further under “Part I, Item 4. Controls and Procedures” of this Form 10-Q.
Notwithstanding the material weaknesses discussed under “Part I, Item 4. Controls and Procedures” of this Form 10-Q and based upon our internal accounting review and the independent review of our Audit Committee, our management has concluded that our consolidated financial statements included in this Form 10-Q are fairly stated in all material respects in accordance with United States Generally Accepted Accounting Principles (“U.S. GAAP”).
Correction of Additional Immaterial Errors. Although the initial focus of the Company’s internal accounting review discussed above pertained to the timing of the recognition of revenue associated with the concessions granted to certain distributors, the Company subsequently expanded its internal accounting review and performed an analysis of previously-issued financial statements to identify and assess any other potential errors. Based upon this review, the Company identified certain immaterial errors relating to its previously-issued financial statements, which resulted in revisions to our previously-issued financial statements and are discussed in further detail under Note 3, Correction of Immaterial Errors to Prior Period Financial Statements, in the Notes to Consolidated Financial Statements included in Item 1 of Part I of this Form 10-Q. Please also see our Periodic Reports, which are being filed concurrently with this Form 10-Q.
Except as specifically set forth herein, the information contained in this Form 10-Q is presented as of March 31, 2017 and the period then ended, and these financial results do not reflect events or results of operations that have occurred subsequent to March 31, 2017.
Unless otherwise indicated, references in this Form 10-Q to 2016 and 2015 or “fiscal” 2016 and 2015 refer to our fiscal year ended June 30 of that respective year, and references to 2017 or “fiscal” 2017 refer to our fiscal year ending June 30, 2017.
2

Table of Contents
Cautionary Note Regarding Forward Looking Information
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 relating to our business and financial outlook, which are based on our current beliefs, assumptions, expectations, estimates, forecasts and projections about future events only as of the date of this Quarterly Report on Form 10-Q and are not statements of historical fact. We make such forward-looking statements pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995.
Many of our forward-looking statements include discussions of trends and anticipated developments under the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of this Quarterly Report on Form 10-Q. In some cases, you can identify forward-looking statements by terminology such as the use of “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “projects,” “intends,” “predicts,” “potential,” or “continue” and similar expressions, or the negative of those expressions. These forward-looking statements include, among other things, our beliefs or expectations relating to our business strategy, growth strategy, market price, brand portfolio and product performance, the seasonality of our business, our results of operations and financial condition, our SEC filings, enhancing internal controls and remediating material weaknesses. These forward-looking statements are not guarantees of our future performance and involve risks, uncertainties, estimates and assumptions that are difficult to predict. Therefore, our actual outcomes and results may differ materially from those expressed in these forward-looking statements. You should not place undue reliance on any of these forward-looking statements. Further, any forward-looking statement speaks only as of the date hereof, unless it is specifically otherwise stated to be made as of a different date. We undertake no obligation to further update any such statement, or the risk factors described in Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2016 under the heading “Risk Factors”, to reflect new information, the occurrence of future events or circumstances or otherwise.
The forward-looking statements in this filing do not constitute guarantees or promises of future performance. Factors that could cause or contribute to such differences may include, but are not limited to, the impact of competitive products, changes to the competitive environment, changes to consumer preferences, general economic and financial market conditions, our ability to introduce new products and improve existing products, changes in relationships with customers, suppliers, strategic partners and lenders, legal proceedings and government investigations (including any potential action by the Division of Enforcement of the SEC and securities class action and stockholder derivative litigation), our ability to manage our financial reporting and internal control systems and processes, the Company’s non-compliance with certain Nasdaq Stock Market LLC listing rules, the expected sales of our products, our ability to identify and complete acquisitions or divestitures and integrate acquisitions, changes in raw materials, commodity costs and fuel, the availability of organic and natural ingredients, risks associated with our international sales and operations, risks relating to the protection of intellectual property, the reputation of our brands, changes to and the interpretation of governmental regulations, unanticipated expenditures, and other risks described in Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2016 under the heading “Risk Factors” and Item 1A, “Risk Factors” set forth herein, as well as in other reports that we file in the future.
3

Table of Contents
PART I - FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
MARCH 31, 2017 AND JUNE 30, 2016
(In thousands, except par values)

| March 31, |  | June 30,
| 2017 |  | 2016
ASSETS | (Unaudited) |  |
Current assets: |  |  |
Cash and cash equivalents | $ | 162,642 |  |  | $ | 127,926 |
Accounts receivable, less allowance for doubtful accounts of $1,721 and $936, respectively | 241,738 |  |  | 278,933 |
Inventories | 435,651 |  |  | 408,564 |
Prepaid expenses and other current assets | 65,017 |  |  | 84,811 |
Total current assets | 905,048 |  |  | 900,234 |
Property, plant and equipment, net | 377,190 |  |  | 389,841 |
Goodwill | 1,032,583 |  |  | 1,060,336 |
Trademarks and other intangible assets, net | 567,425 |  |  | 604,787 |
Investments and joint ventures | 18,976 |  |  | 20,244 |
Other assets | 32,361 |  |  | 32,638 |
Total assets | $ | 2,933,583 |  |  | $ | 3,008,080 |
LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |
Current liabilities: |  |  |
Accounts payable | $ | 237,188 |  |  | $ | 251,712 |
Accrued expenses and other current liabilities | 101,027 |  |  | 78,803 |
Current portion of long-term debt | 8,457 |  |  | 26,513 |
Total current liabilities | 346,672 |  |  | 357,028 |
Long-term debt, less current portion | 780,868 |  |  | 836,171 |
Deferred income taxes | 123,954 |  |  | 131,507 |
Other noncurrent liabilities | 16,566 |  |  | 18,860 |
Total liabilities | 1,268,060 |  |  | 1,343,566 |
Commitments and contingencies (Note 15) |  |  |
Stockholders’ equity: |  |  |
Preferred stock - $.01 par value, authorized: 5,000 shares; issued and outstanding: none | — |  |  | — |
Common stock - $.01 par value, authorized: 150,000 shares; issued: 107,969 and 107,479 shares, respectively; outstanding: 103,690 and 103,461 shares, respectively | 1,080 |  |  | 1,075 |
Additional paid-in capital | 1,135,788 |  |  | 1,123,206 |
Retained earnings | 868,509 |  |  | 801,392 |
Accumulated other comprehensive loss | (240,871 | ) |  | (172,111 | )
| 1,764,506 |  |  | 1,753,562 |
Less: Treasury stock, at cost: 4,279 and 4,018 shares, respectively | (98,983 | ) |  | (89,048 | )
Total stockholders’ equity | 1,665,523 |  |  | 1,664,514 |
Total liabilities and stockholders’ equity | $ | 2,933,583 |  |  | $ | 3,008,080 |

See notes to consolidated financial statements.
4

Table of Contents
THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
FOR THE THREE AND NINE MONTHS ENDED MARCH 31, 2017 AND 2016
(In thousands, except per share amounts)

| Three Months Ended March 31, |  | Nine Months Ended March 31,
| 2017 |  | 2016 |  | 2017 |  | 2016
Net sales | $ | 706,563 |  |  | $ | 736,663 |  |  | $ | 2,128,026 |  |  | $ | 2,147,827 |
Cost of sales | 563,170 |  |  | 576,755 |  |  | 1,736,373 |  |  | 1,683,777 |
Gross profit | 143,393 |  |  | 159,908 |  |  | 391,653 |  |  | 464,050 |
Selling, general and administrative expenses | 82,576 |  |  | 78,890 |  |  | 252,730 |  |  | 223,421 |
Amortization of acquired intangibles | 4,543 |  |  | 4,553 |  |  | 13,964 |  |  | 13,896 |
Acquisition related expenses, restructuring and integration charges and other | 2,083 |  |  | 5,317 |  |  | 2,652 |  |  | 11,235 |
Accounting review costs | 7,124 |  |  | — |  |  | 20,089 |  |  | — |
Operating income | 47,067 |  |  | 71,148 |  |  | 102,218 |  |  | 215,498 |
Interest and other financing expense, net | 5,439 |  |  | 6,920 |  |  | 15,617 |  |  | 19,687 |
Other (income)/expense, net | 2,072 |  |  | 378 |  |  | 207 |  |  | 8,844 |
Gain on fire insurance recovery | — |  |  | (9,013 | ) |  | — |  |  | (9,013 | )
Income before income taxes and equity in net (income) loss of equity-method investees | 39,556 |  |  | 72,863 |  |  | 86,394 |  |  | 195,980 |
Provision for income taxes | 8,051 |  |  | 23,914 |  |  | 19,322 |  |  | 59,846 |
Equity in net (income) loss of equity-method investees | 177 |  |  | 161 |  |  | (45 | ) |  | 108 |
Net income | $ | 31,328 |  |  | $ | 48,788 |  |  | $ | 67,117 |  |  | $ | 136,026 |
Net income per common share: |  |  |  |  |  |  |
Basic | $ | 0.30 |  |  | $ | 0.47 |  |  | $ | 0.65 |  |  | $ | 1.32 |
Diluted | $ | 0.30 |  |  | $ | 0.47 |  |  | $ | 0.64 |  |  | $ | 1.31 |
Weighted average common shares outstanding: |  |  |  |  |  |  |
Basic | 103,687 |  |  | 103,265 |  |  | 103,584 |  |  | 103,030 |
Diluted | 104,246 |  |  | 104,087 |  |  | 104,232 |  |  | 104,168 |

See notes to consolidated financial statements.
5

Table of Contents
THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)
FOR THE THREE AND NINE MONTHS ENDED MARCH 31, 2017 AND 2016
(In thousands)

| Three Months Ended
| March 31, 2017 |  | March 31, 2016
| Pre-tax amount |  | Tax (expense) benefit |  | After-tax amount |  | Pre-tax amount |  | Tax (expense) benefit |  | After-tax amount
Net income |  |  |  |  | $ | 31,328 |  |  |  |  |  |  | $ | 48,788 |
Other comprehensive income (loss): |  |  |  |  |  |  |  |  |  |  |
Foreign currency translation adjustments | $ | 14,630 |  |  | $ | — |  |  | 14,630 |  |  | $ | (20,103 | ) |  | $ | — |  |  | (20,103 | )
Change in deferred gains (losses) on cash flow hedging instruments | (21 | ) |  | 4 |  |  | (17 | ) |  | (1,610 | ) |  | 401 |  |  | (1,209 | )
Change in unrealized gain on available for sale investment | 83 |  |  | (33 | ) |  | 50 |  |  | 33 |  |  | (13 | ) |  | 20 |
Total other comprehensive income (loss) | $ | 14,692 |  |  | $ | (29 | ) |  | $ | 14,663 |  |  | $ | (21,680 | ) |  | $ | 388 |  |  | $ | (21,292 | )
Total comprehensive income (loss) |  |  |  |  | $ | 45,991 |  |  |  |  |  |  | $ | 27,496 |
| Nine Months Ended
| March 31, 2017 |  | March 31, 2016
| Pre-tax amount |  | Tax (expense) benefit |  | After-tax amount |  | Pre-tax amount |  | Tax (expense) benefit |  | After-tax amount
Net income |  |  |  |  | $ | 67,117 |  |  |  |  |  |  | $ | 136,026 |
Other comprehensive income (loss): |  |  |  |  |  |  |  |  |  |  |
Foreign currency translation adjustments | $ | (68,329 | ) |  | $ | — |  |  | (68,329 | ) |  | $ | (85,690 | ) |  | $ | — |  |  | (85,690 | )
Change in deferred gains (losses) on cash flow hedging instruments | (464 | ) |  | 42 |  |  | (422 | ) |  | (288 | ) |  | 124 |  |  | (164 | )
Change in unrealized gain on available for sale investment | (6 | ) |  | (3 | ) |  | (9 | ) |  | (183 | ) |  | 71 |  |  | (112 | )
Total other comprehensive income (loss) | $ | (68,799 | ) |  | $ | 39 |  |  | $ | (68,760 | ) |  | $ | (86,161 | ) |  | $ | 195 |  |  | $ | (85,966 | )
Total comprehensive income (loss) |  |  |  |  | $ | (1,643 | ) |  |  |  |  |  | $ | 50,060 |

See notes to consolidated financial statements.
6

Table of Contents
THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY (UNAUDITED)
FOR THE NINE MONTHS ENDED MARCH 31, 2017
(In thousands, except par values)

| Common Stock |  | Additional |  |  |  |  |  |  |  | Accumulated Other |  |
|  |  | Amount |  | Paid-in |  | Retained |  | Treasury Stock |  | Comprehensive |  |
| Shares |  | at $.01 |  | Capital |  | Earnings |  | Shares |  | Amount |  | Income (Loss) |  | Total
Balance at June 30, 2016 | 107,479 |  |  | $ | 1,075 |  |  | $ | 1,123,206 |  |  | $ | 801,392 |  |  | 4,018 |  |  | $ | (89,048 | ) |  | $ | (172,111 | ) |  | $ | 1,664,514 |
Net income |  |  |  |  |  |  | 67,117 |  |  |  |  |  |  |  |  | 67,117 |
Other comprehensive income (loss) |  |  |  |  |  |  |  |  |  |  |  |  | (68,760 | ) |  | (68,760 | )
Issuance of common stock pursuant to stock based compensation plans | 490 |  |  | 5 |  |  | 1,994 |  |  |  |  | 2 |  |  | (1,999 | ) |  |  |  | — |
Stock-based compensation income tax effects |  |  |  |  | 3,069 |  |  |  |  |  |  |  |  |  |  | 3,069 |
Shares withheld for payment of employee payroll taxes due on shares issued under stock based compensation plans |  |  |  |  |  |  |  |  | 259 |  |  | (7,936 | ) |  |  |  | (7,936 | )
Stock-based compensation expense |  |  |  |  | 7,519 |  |  |  |  |  |  |  |  |  |  | 7,519 |
Balance at March 31, 2017 | 107,969 |  |  | 1,080 |  |  | 1,135,788 |  |  | 868,509 |  |  | 4,279 |  |  | (98,983 | ) |  | (240,871 | ) |  | 1,665,523 |

See notes to consolidated financial statements.
7

Table of Contents
THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
FOR THE NINE MONTHS ENDED MARCH 31, 2017 AND 2016
(In thousands)

| Nine Months Ended March 31,
| 2017 |  | 2016
CASH FLOWS FROM OPERATING ACTIVITIES |  |  |
Net income | $ | 67,117 |  |  | $ | 136,026 |
Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
Depreciation and amortization | 51,300 |  |  | 48,099 |
Deferred income taxes | (6,543 | ) |  | (9,532 | )
Equity in net income of equity-method investees | (45 | ) |  | 108 |
Stock based compensation | 7,519 |  |  | 10,005 |
Contingent consideration expense | — |  |  | 1,511 |
Gain on fire recovery and other, net | — |  |  | (8,401 | )
Other non-cash items including unrealized foreign currency (gains) losses, net | (363 | ) |  | 7,403 |
Increase (decrease) in cash attributable to changes in operating assets and liabilities, net of amounts applicable to acquisitions: |  |  |
Accounts receivable | 25,721 |  |  | (30,461 | )
Inventories | (35,194 | ) |  | (10,776 | )
Other current assets | 20,356 |  |  | 22,041 |
Other assets and liabilities | (1,801 | ) |  | 1,111 |
Accounts payable and accrued expenses | 19,885 |  |  | (35,280 | )
Net cash provided by operating activities | 147,952 |  |  | 131,854 |
CASH FLOWS FROM INVESTING ACTIVITIES |  |  |
Acquisitions of businesses, net of cash acquired and working capital settlements | — |  |  | (157,061 | )
Purchases of property and equipment | (44,064 | ) |  | (58,022 | )
Proceeds from sale of business | 5,419 |  |  | — |
Other | 1,000 |  |  | — |
Net cash used in investing activities | (37,645 | ) |  | (215,083 | )
CASH FLOWS FROM FINANCING ACTIVITIES |  |  |
Borrowings under bank revolving credit facility | 22,000 |  |  | 173,904 |
Repayments under bank revolving credit facility | (67,500 | ) |  | (110,053 | )
Borrowings (repayments) of other debt, net | (18,145 | ) |  | (2,378 | )
Excess tax benefits from stock-based compensation | 3,338 |  |  | 11,308 |
Acquisition related contingent consideration | (2,498 | ) |  | — |
Shares withheld for payment of employee payroll taxes | (7,936 | ) |  | (25,158 | )
Net cash (used in) provided by financing activities | (70,741 | ) |  | 47,623 |
Effect of exchange rate changes on cash | (4,850 | ) |  | (5,926 | )
Net increase (decrease) in cash and cash equivalents | 34,716 |  |  | (41,532 | )
Cash and cash equivalents at beginning of period | 127,926 |  |  | 166,922 |
Cash and cash equivalents at end of period | $ | 162,642 |  |  | $ | 125,390 |

See notes to consolidated financial statements.
8

Table of Contents
THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(Amounts in thousands, except par values and per share data)
1. BUSINESS
The Hain Celestial Group, Inc., a Delaware corporation, and its subsidiaries (collectively, “Hain Celestial” or the “Company,” and herein referred to as “we,” “us,” and “our”) was founded in 1993 and is headquartered in Lake Success, New York. The Company’s mission has continued to evolve since its founding, with health and wellness being the core tenet — to be the leading marketer, manufacturer and seller of organic and natural, “better-for-you” products by anticipating and exceeding consumer expectations in providing quality, innovation, value and convenience. The Company is committed to growing sustainably while continuing to implement environmentally sound business practices and manufacturing processes. Hain Celestial sells its products through specialty and natural food distributors, supermarkets, natural food stores, mass-market and e-commerce retailers, food service channels and club, drug and convenience stores in over 80 countries worldwide.
With a proven track record of strategic growth and profitability, the Company manufactures, markets, distributes and sells organic and natural products under brand names that are sold as “better-for-you” products, providing consumers with the opportunity to lead A Healthier Way of LifeTM. Hain Celestial is a leader in many organic and natural products categories, with many recognized brands in the various market categories it serves, including Almond Dream®, Arrowhead Mills®, Bearitos®, BluePrint®, Celestial Seasonings®, Coconut Dream®, Cully & Sully®, Danival®, DeBoles®, Earth’s Best®, Ella’s Kitchen®, Empire®, Europe’s Best®, Farmhouse Fare®, Frank Cooper’s®, FreeBird®, Gale’s®, Garden of Eatin’®, GG UniqueFiberTM, Hain Pure Foods®, Hartley’s®, Health Valley®, Imagine®, Johnson’s Juice Co.®, Joya®, Kosher Valley®, Lima®, Linda McCartney’s® (under license), MaraNatha®, Natumi®, New Covent Garden Soup Co.®, Plainville Farms®, Rice Dream®, Robertson’s®, Rudi’s Gluten-Free Bakery®, Rudi’s Organic Bakery®, Sensible Portions®, Spectrum Organics®, Soy Dream®, Sun-Pat®, SunSpire®, Terra®, The Greek Gods®, Tilda®, WestSoy® and Yves Veggie Cuisine®. The Company’s personal care products are marketed under the Alba Botanica®, Avalon Organics®, Earth’s Best®, JASON®, Live Clean® and Queen Helene® brands.
During fiscal year 2016, the Company commenced a strategic review, which it called “Project Terra,” that resulted in the Company redefining its core platforms, starting with the United States segment, for future growth based upon consumer trends to create and inspire A Healthier Way of Life™. In addition, beginning in fiscal year 2017, the Company launched Cultivate Ventures (“Cultivate”), a venture unit with a threefold purpose: (i) to strategically invest in the Company’s smaller brands in high potential categories such as BluePrint® cold-pressed juices, SunSpire® chocolates and DeBoles® pasta by giving those products a dedicated, creative focus for refresh and relaunch; (ii) to incubate small acquisitions until they reach the scale for the Company’s core platforms; and (iii) to invest in concepts, products and technology that focus on health and wellness. See Note 16, Segment Information, for information on the Company’s operating and reportable segments and the effect the formation of Cultivate had thereon.
2. BASIS OF PRESENTATION
The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP. The amounts as of and for the periods ended June 30, 2016 are derived from the Company’s audited annual financial statements. The consolidated financial statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair presentation for interim periods. Operating results for the three and nine months ended March 31, 2017 are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2017. Please refer to the notes to the Consolidated Financial Statements as of June 30, 2016 and for the fiscal year then ended included in the Company’s Annual Report on Form 10-K (the “Form 10-K”) for information not included in these condensed notes.
All amounts in the consolidated financial statements, notes and tables have been rounded to the nearest thousand, except par values and per share amounts, unless otherwise indicated.
Recently Issued Accounting Pronouncements Not Yet Effective
Refer to Note 3, Summary of Significant Accounting Policies and Practices, in the Notes to the Consolidated Financial Statements as of June 30, 2016 and for the fiscal year then ended included in the Form 10-K for a detailed discussion on recently issued accounting pronouncements not yet adopted by the Company. There has been no change to the statements made in the Form 10-K as of the date of filing of this Form 10-Q.
9

Table of Contents
3. CORRECTION OF IMMATERIAL ERRORS TO PRIOR PERIOD FINANCIAL STATEMENTS
Accounting Review
During the fourth quarter of fiscal 2016, the Company identified the practice of granting additional concessions to certain distributors in the United States and commenced an internal accounting review in order to (i) determine whether the revenue associated with those concessions was accounted for in the correct period and (ii) evaluate the Company’s internal control over financial reporting. The Audit Committee of the Company’s Board of Directors separately conducted an independent review of these matters and retained independent counsel to assist in their review. On November 16, 2016, the Company announced that the independent review of the Audit Committee was completed and that the review found no evidence of intentional wrongdoing in connection with the preparation of the Company’s financial statements. The aforementioned reviews identified material weaknesses in our internal control over financial reporting. Refer to “Part I, Item 4. Controls and Procedures” of the Form 10-Q for a description of these material weaknesses and management’s plan and implementation of remediation efforts to address these material weaknesses.
Although the initial focus of the Company’s internal accounting review discussed above pertained to the evaluation of the timing of the recognition of the revenue associated with the practice of granting additional concessions to certain distributors, the Company subsequently expanded its internal accounting review and performed an analysis of previously-issued financial statements in order to identify and assess other potential errors. Based upon this review, the Company identified certain immaterial errors relating to its previously-issued financial statements which resulted in revisions to our previously-issued financial statements. Accordingly, prior period amounts presented in the consolidated financial statements and the related notes have been revised (referred to as the “Revision”). All costs incurred in connection with the internal accounting review, the Audit Committee’s independent review and related matters are included in “Accounting review costs,” in the Company’s Consolidated Statements of Income.
Based on an analysis of Accounting Standards Codification (“ASC”) 250 - “Accounting Changes and Error Corrections” (“ASC 250”), Staff Accounting Bulletin 99 - “Materiality” (“SAB 99”) and Staff Accounting Bulletin 108 - Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements (“SAB 108”), the Company determined that these errors were immaterial to the previously-issued financial statements; however, a cumulative correction of these errors would have had a material impact on the financial results for the three and twelve months ended June 30, 2016. Accordingly, we have revised our presentation of certain amounts in the consolidated financial statements for the three and nine months ended March 31, 2016 to reflect such corrections as if they had been recorded in the appropriate fiscal period.
We refer the reader to the Company’s Form 10-K for the fiscal year ended June 30, 2016 for a detailed explanation of the immaterial errors.
10

Table of Contents
Revised Financial Statements
The impact of the Revision on the Company’s previously-issued financial statements is illustrated in the tables below. Amounts throughout the consolidated financial statements and notes thereto have been adjusted to incorporate the revised amounts, where applicable.
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)

| Three Months Ended March 31, 2016
| As Reported |  | Adjustment |  | As Revised
Net sales | $ | 749,862 |  |  | $ | (13,199 | ) |  | $ | 736,663 |
Cost of sales | 576,653 |  |  | 102 |  |  | 576,755 |
Gross profit | 173,209 |  |  | (13,301 | ) |  | 159,908 |
Selling, general and administrative expenses | 93,915 |  |  | (15,025 | ) |  | 78,890 |
Amortization of acquired intangibles | 4,586 |  |  | (33 | ) |  | 4,553 |
Acquisition related expenses, restructuring and integration charges and other | 5,701 |  |  | (384 | ) |  | 5,317 |
Operating income | 69,007 |  |  | 2,141 |  |  | 71,148 |
Interest and other financing expense, net | 6,920 |  |  | — |  |  | 6,920 |
Other (income)/expense, net | 378 |  |  | — |  |  | 378 |
Gain on fire insurance recovery | (9,013 | ) |  |  |  | (9,013 | )
Income before income taxes and equity in earnings of equity- method investees | 70,722 |  |  | 2,141 |  |  | 72,863 |
Provision for income taxes | 21,576 |  |  | 2,338 |  |  | 23,914 |
Equity in net income of equity-method investees | 161 |  |  | — |  |  | 161 |
Net income | $ | 48,985 |  |  | $ | (197 | ) |  | $ | 48,788 |
Net income per common share: |  |  |  |  |
Basic | $ | 0.47 |  |  | $ | — |  |  | $ | 0.47 |
Diluted | $ | 0.47 |  |  | $ | — |  |  | $ | 0.47 |
Weighted average common shares outstanding: |  |  |  |  |
Basic | 103,265 |  |  | 103,265 |  |  | 103,265 |
Diluted | 104,087 |  |  | 104,087 |  |  | 104,087 |

* Net income per common share may not add in certain periods due to rounding
11

Table of Contents
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (CONTINUED)

| Nine Months Ended March 31, 2016
| As Reported |  | Adjustment |  | As Revised
Net sales | $ | 2,189,639 |  |  | $ | (41,812 | ) |  | $ | 2,147,827 |
Cost of sales | 1,686,820 |  |  | (3,043 | ) |  | 1,683,777 |
Gross profit | 502,819 |  |  | (38,769 | ) |  | 464,050 |
Selling, general and administrative expenses | 262,776 |  |  | (39,355 | ) |  | 223,421 |
Amortization/impairment of acquired intangibles | 13,994 |  |  | (98 | ) |  | 13,896 |
Acquisition related expenses, restructuring and integration charges and other | 11,852 |  |  | (617 | ) |  | 11,235 |
Operating income | 214,197 |  |  | 1,301 |  |  | 215,498 |
Interest and other financing expense, net | 19,760 |  |  | (73 | ) |  | 19,687 |
Other (income)/expense, net | 8,771 |  |  | 73 |  |  | 8,844 |
Gain on fire insurance recovery | (9,013 | ) |  | — |  |  | (9,013 | )
Income before income taxes and equity in earnings of equity- method investees | 194,679 |  |  | 1,301 |  |  | 195,980 |
Provision for income taxes | 57,337 |  |  | 2,509 |  |  | 59,846 |
Equity in net income of equity-method investees | 108 |  |  | — |  |  | 108 |
Net income | 137,234 |  |  | (1,208 | ) |  | 136,026 |
Net income per common share: |  |  |  |  |
Basic | $ | 1.33 |  |  | $ | (0.01 | ) |  | $ | 1.32 |
Diluted | $ | 1.32 |  |  | $ | (0.01 | ) |  | $ | 1.31 |
Weighted average common shares outstanding: |  |  |  |  |
Basic | 103,030 |  |  | 103,030 |  |  | 103,030 |
Diluted | 104,168 |  |  | 104,168 |  |  | 104,168 |

* Net income per common share may not add in certain periods due to rounding
12

Table of Contents
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

|  | Three Months Ended March 31, 2016 |  | Nine Months Ended March 31, 2016
|  | As Reported |  | Adjustment |  | As Revised |  | As Reported |  | Adjustment |  | As Revised
Net income |  | $ | 48,985 |  |  | $ | (197 | ) |  | $ | 48,788 |  |  | $ | 137,234 |  |  | $ | (1,208 | ) |  | $ | 136,026 |
Other comprehensive income (loss): |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency translation adjustments |  | $ | (20,296 | ) |  | $ | 193 |  |  | (20,103 | ) |  | $ | (86,380 | ) |  | 690 |  |  | (85,690 | )
Change in deferred gains (losses) on cash flow hedging instruments |  | (1,209 | ) |  | — |  |  | (1,209 | ) |  | (164 | ) |  | — |  |  | (164 | )
Change in unrealized gain (loss) on available for sale investment |  | 20 |  |  | — |  |  | 20 |  |  | (112 | ) |  | — |  |  | (112 | )
Total other comprehensive income (loss) |  | $ | (21,485 | ) |  | $ | 193 |  |  | $ | (21,292 | ) |  | $ | (86,656 | ) |  | $ | 690 |  |  | $ | (85,966 | )
Total comprehensive income |  | $ | 27,500 |  |  | $ | (4 | ) |  | $ | 27,496 |  |  | $ | 50,578 |  |  | $ | (518 | ) |  | $ | 50,060 |

13

Table of Contents
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

| Nine Months Ended March 31, 2016
| As Reported |  | Adjustment |  | As Revised
CASH FLOWS FROM OPERATING ACTIVITIES |  |  |  |  |
Net income | $ | 137,234 |  |  | $ | (1,208 | ) |  | $ | 136,026 |
Adjustments to reconcile net income to net cash provided by (used in) operating activities: |  |  |  |  |
Depreciation and amortization | 47,494 |  |  | 605 |  |  | 48,099 |
Deferred income taxes | (9,377 | ) |  | (155 | ) |  | (9,532 | )
Equity in net income of equity-method investees | 108 |  |  | — |  |  | 108 |
Stock-based compensation | 10,005 |  |  | — |  |  | 10,005 |
Contingent consideration expense | 1,511 |  |  | — |  |  | 1,511 |
Gain on fire insurance recovery and other, net | (8,401 | ) |  | — |  |  | (8,401 | )
Other non-cash items, including unrealized currency (gains)/loss, net | 7,403 |  |  | — |  |  | 7,403 |
Increase (decrease) in cash attributable to changes in operating assets and liabilities, net of amounts applicable to acquisitions: |  |  |  |  |
Accounts receivable | (29,201 | ) |  | (1,260 | ) |  | (30,461 | )
Inventories | (11,397 | ) |  | 621 |  |  | (10,776 | )
Other current assets | (650 | ) |  | 22,691 |  |  | 22,041 |
Other assets and liabilities | 1,111 |  |  | — |  |  | 1,111 |
Accounts payable and accrued expenses | (13,986 | ) |  | (21,294 | ) |  | (35,280 | )
Net cash provided by operating activities | $ | 131,854 |  |  | $ | — |  |  | $ | 131,854 |

There were no adjustments to cash balances and to cash flows from investing and financing activities for the nine months ended March 31, 2016 as a result of the Revision.
14

Table of Contents
SEGMENT NET SALES AND OPERATING INCOME (UNAUDITED)

| Three months ended March 31, 2016
| As Reported (1) |  | Adjustment |  | As Revised
Net Sales: |  |  |  |  |
United States | $ | 332,904 |  |  | $ | (7,520 | ) |  | $ | 325,384 |
United Kingdom | 208,391 |  |  | (2,231 | ) |  | $ | 206,160 |
Hain Pure Protein | 113,643 |  |  | (1,430 | ) |  | $ | 112,213 |
Rest of World | 94,924 |  |  | (2,018 | ) |  | $ | 92,906 |
| $ | 749,862 |  |  | $ | (13,199 | ) |  | $ | 736,663 |
Operating Income: |  |  |  |  |
United States | $ | 52,103 |  |  | $ | 4,278 |  |  | $ | 56,381 |
United Kingdom | 16,217 |  |  | (391 | ) |  | $ | 15,826 |
Hain Pure Protein | 4,613 |  |  | (2,186 | ) |  | $ | 2,427 |
Rest of World | 8,641 |  |  | (509 | ) |  | $ | 8,132 |
| $ | 81,574 |  |  | $ | 1,192 |  |  | $ | 82,766 |
Corporate and Other | (12,567 | ) |  | 949 |  |  | (11,618 | )
| $ | 69,007 |  |  | $ | 2,141 |  |  | $ | 71,148 |

(1) The information previously reported for the three months ended March 31, 2016 has been adjusted to reflect the Company’s
new operating and reporting structure effective in the first quarter of fiscal 2017. See Note 1, Business, and Note 16, Segment
Information, for additional details surrounding the formation of Cultivate.

| Nine months ended March 31, 2016
| As Reported (1) |  | Adjustment |  | As Revised
Net Sales: |  |  |  |  |
United States | $ | 970,368 |  |  | $ | (27,668 | ) |  | $ | 942,700 |
United Kingdom | 567,971 |  |  | (9,702 | ) |  | $ | 558,269 |
Hain Pure Protein | 379,337 |  |  | 122 |  |  | $ | 379,459 |
Rest of World | 271,963 |  |  | (4,564 | ) |  | $ | 267,399 |
| $ | 2,189,639 |  |  | $ | (41,812 | ) |  | $ | 2,147,827 |
Operating Income: |  |  |  |  |
United States | $ | 144,305 |  |  | $ | 4,523 |  |  | $ | 148,828 |
United Kingdom | 45,189 |  |  | (1,096 | ) |  | $ | 44,093 |
Hain Pure Protein | 33,009 |  |  | (1,931 | ) |  | $ | 31,078 |
Rest of World | 17,910 |  |  | (264 | ) |  | $ | 17,646 |
| $ | 240,413 |  |  | $ | 1,232 |  |  | $ | 241,645 |
Corporate and Other | (26,216 | ) |  | 69 |  |  | (26,147 | )
| $ | 214,197 |  |  | $ | 1,301 |  |  | $ | 215,498 |

(1) The information previously reported for the nine months ended March 31, 2016 has been adjusted to reflect the Company’s
new operating and reporting structure effective in the first quarter of fiscal 2017. See Note 1, Business, and Note 16, Segment
Information, for additional details surrounding the formation of Cultivate.
15

Table of Contents
4. EARNINGS PER SHARE
The following table sets forth the computation of basic and diluted earnings per share:

| Three Months Ended March 31, |  | Nine Months Ended March 31,
| 2017 |  | 2016 |  | 2017 |  | 2016
Numerator: |  |  |  |  |  |  |
Net income | $ | 31,328 |  |  | $ | 48,788 |  |  | $ | 67,117 |  |  | $ | 136,026 |
Denominator (in thousands): |  |  |  |  |  |  |
Basic earnings per share - weighted average shares outstanding during the period | 103,687 |  |  | 103,265 |  |  | 103,584 |  |  | 103,030 |
Effect of dilutive stock options, unvested restricted stock and unvested restricted share units | 559 |  |  | 822 |  |  | 648 |  |  | 1,138 |
Diluted earnings per share - adjusted weighted average shares and assumed conversions | 104,246 |  |  | 104,087 |  |  | 104,232 |  |  | 104,168 |
Net income per common share: |  |  |  |  |  |  |
Basic | $ | 0.30 |  |  | $ | 0.47 |  |  | $ | 0.65 |  |  | $ | 1.32 |
Diluted | $ | 0.30 |  |  | $ | 0.47 |  |  | $ | 0.64 |  |  | $ | 1.31 |

Basic earnings per share excludes the dilutive effects of stock options, unvested restricted stock and unvested restricted share units. Diluted earnings per share includes the dilutive effects of common stock equivalents such as stock options and unvested restricted stock awards.
There were 271 and 282 stock based awards excluded from our diluted earnings per share calculations for the three and nine months ended March 31, 2017 and 2016, respectively, as such awards were contingently issuable based on market or performance conditions, and such conditions had not been achieved during the respective periods. Additionally, 5 and 195 restricted stock awards were excluded from our diluted earnings per share calculation for both the three and nine months ended March 31, 2017 and 2016, respectively, as such awards were antidilutive.
Share-Repurchase Program
On June 21, 2017, the Company's Board of Directors authorized the repurchase of up to $250,000 of the Company’s issued and outstanding common stock. The extent to which the Company repurchases its shares and the timing of such repurchases will depend upon market conditions and other corporate considerations including the Company’s historical strategy of pursuing accretive acquisitions.
5. ACQUISITIONS
The Company accounts for acquisitions in accordance with ASC 805, Business Combinations. The results of operations of the acquisitions have been included in the consolidated results from their respective dates of acquisition. The purchase price of each acquisition is allocated to the tangible assets, liabilities and identifiable intangible assets acquired based on their estimated fair values. Acquisitions may include contingent consideration, the fair value of which is estimated on the acquisition date as the present value of the expected contingent payments, determined using weighted probabilities of possible payments. The fair values assigned to identifiable intangible assets acquired were determined primarily by using an income approach which was based on assumptions and estimates made by management. Significant assumptions utilized in the income approach were based on Company specific information and projections which are not observable in the market and are thus considered Level 3 measurements as defined by authoritative guidance. The excess of the purchase price over the fair value of the identified assets and liabilities has been recorded as goodwill.
The costs related to all acquisitions have been expensed as incurred and are included in “Acquisition related expenses, restructuring and integration charges and other” in the Consolidated Statements of Income. Acquisition related expenses of $836 and $1,089 were expensed in the three and nine months ended March 31, 2017, respectively, and $720 and $3,681 were expensed in the three and nine months ended March 31, 2016, respectively. The expenses incurred during the first nine months of fiscal 2017 and 2016 primarily related to the acquisitions of Orchard House and Mona (as defined below).
16

Table of Contents
Fiscal 2016
On December 21, 2015, the Company acquired Orchard House Foods Limited (“Orchard House”), a leader in pre-cut fresh fruit, juices, fruit desserts and ingredients with facilities in Corby and Gateshead in the United Kingdom. Orchard House supplies leading retailers, on-the-go food outlets, food service providers and manufacturers in the United Kingdom. Consideration in the transaction consisted of cash (net of cash acquired) totaling £76,923 ($114,113 at the transaction date exchange rate). The acquisition was funded with borrowings under the Credit Agreement (as defined in Note 9, Debt and Borrowings). Additionally, contingent consideration of £3,000 was potentially payable to the sellers based on the outcome of a review by the Competition and Markets Authority in the United Kingdom. As a result of this review, the Company agreed to divest certain portions of its own-label juice business in the fourth quarter of fiscal 2016. On September 15, 2016, the contingent consideration obligation referenced above was settled in the amount of £1,500 (see Note 14, Financial Instruments Measured at Fair Value). Orchard House is included in the United Kingdom operating segment.
On July 24, 2015, the Company acquired Formatio Beratungs-und Beteiligungs GmbH and its subsidiaries (“Mona”), a leader in plant-based foods and beverages with facilities in Germany and Austria. Mona offers a wide range of organic and natural products under the Joya® and Happy® brands, including soy, oat, rice and nut based drinks as well as plant-based yogurts, desserts, creamers, tofu and private label products, sold to leading retailers in Europe, primarily in Austria and Germany and eastern European countries. Consideration in the transaction consisted of cash, net of cash acquired, totaling €22,753 ($24,948 at the transaction date exchange rate) and 240 shares of the Company’s common stock valued at $16,308. Also included in the acquisition was the assumption of net debt totaling €16,252. The cash portion of the purchase price was funded with borrowings under our Credit Agreement. Mona is included in the Europe operating segment.
The following table provides unaudited pro forma results of continuing operations for the nine months ended March 31, 2016, as if the acquisitions of Orchard House and Mona had been completed at the beginning of fiscal 2016. Pro forma results of continuing operations for the three months ended March 31, 2016 are not presented in the following table as the actual results for these acquisitions are already included in the Company’s financial results for the quarter ended March 31, 2016. The information has been provided for illustrative purposes only and does not purport to be indicative of the actual results that would have been achieved by the Company for the period presented or that will be achieved by the combined company in the future. The pro forma information has been adjusted to give effect to items that are directly attributable to the transactions and are expected to have a continuing impact on the combined results.

| Nine Months ended March 31, 2016
Net sales | $ | 2,236,144 |
Net income | $ | 138,448 |
Net income per diluted common share | $ | 1.33 |

6. INVENTORIES
Inventories consisted of the following:

| March 31, 2017 |  | June 30, 2016
Finished goods | $ | 276,581 |  |  | $ | 238,184 |
Raw materials, work-in-progress and packaging | 159,070 |  |  | 170,380 |
| $ | 435,651 |  |  | $ | 408,564 |

17

Table of Contents
7. PROPERTY, PLANT AND EQUIPMENT, NET
Property, plant and equipment, net consisted of the following:

| March 31, 2017 |  | June 30, 2016
Land | $ | 32,871 |  |  | $ | 35,825 |
Buildings and improvements | 109,573 |  |  | 102,086 |
Machinery and equipment | 358,462 |  |  | 358,362 |
Computer hardware and software | 49,312 |  |  | 48,829 |
Furniture and fixtures | 15,121 |  |  | 14,165 |
Leasehold improvements | 28,014 |  |  | 28,471 |
Construction in progress | 17,629 |  |  | 14,495 |
| 610,982 |  |  | 602,233 |
Less: Accumulated depreciation and amortization | 233,792 |  |  | 212,392 |
| $ | 377,190 |  |  | $ | 389,841 |

Depreciation and amortization expense for the three months ended March 31, 2017 and 2016 was $10,222 and $9,352, respectively. Such expense for the nine months ended March 31, 2017 and 2016 was $30,338 and $27,741, respectively.
18

Table of Contents
8. GOODWILL AND OTHER INTANGIBLE ASSETS
Goodwill
The following table shows the changes in the carrying amount of goodwill by business segment:

| United States |  | United Kingdom |  | Hain Pure Protein |  | Rest of World |  | Total
Net goodwill as of June 30, 2016 (a): | $ | 605,702 |  |  | $ | 332,561 |  |  | $ | 41,089 |  |  | $ | 80,984 |  |  | $ | 1,060,336 |
Reallocation of goodwill between reporting units | (16,377 | ) |  | — |  |  | — |  |  | 16,377 |  |  | — |
Translation and other adjustments, net | (2,098 | ) |  | (23,367 | ) |  | — |  |  | (2,288 | ) |  | (27,753 | )
Net goodwill as of March 31, 2017 (a): | $ | 587,227 |  |  | $ | 309,194 |  |  | $ | 41,089 |  |  | $ | 95,073 |  |  | $ | 1,032,583 |

(a) The total carrying value of goodwill is reflected net of $126,577 of accumulated impairment charges, of which $97,358 related to the Company’s United Kingdom operating segment and $29,219 related to the Company’s Europe operating segment.
The Company performs its annual test for goodwill and indefinite lived intangible asset impairment as of the first day of the fourth quarter of its fiscal year. In addition, if and when events or circumstances change that would more likely than not reduce the fair value of any of its reporting units or indefinite-life intangible assets below their carrying value, an interim test is performed.
During fiscal 2016, the Company recorded a goodwill impairment charge of $82,614 related to its Hain Daniels reporting unit in the United Kingdom. Additionally, a goodwill impairment charge of $1,934 was recognized during the fiscal year ended June 30, 2016 related to the divestiture of certain portions of the Company’s own-label juice business in connection with the Orchard House acquisition, which was sold in the first quarter of fiscal 2017. See Note 5, Acquisitions, for details.
During the first quarter of fiscal 2017, changes in the Company’s internal management and reporting structure resulted in a change in operating segments. Certain brands previously included within the United States operating segment were moved to a new operating segment called Cultivate, which is now combined with Canada and Europe and reported within the “Rest of World” reportable segment. As such, goodwill was reallocated using a relative fair value allocation approach from the United States reportable segment to the Rest of World reportable segment. See Note 1, Business, and Note 16, Segment Information, for additional details surrounding Cultivate and the change in segments.
This change in operating segments was deemed a triggering event, resulting in the Company performing an interim goodwill impairment analysis on the reporting units impacted by this segment change as of immediately before and immediately after the change. There were no impairment indicators resulting from this analysis, and there were no impairment charges recorded during the nine months ended March 31, 2017.
Other Intangible Assets
The following table sets forth balance sheet information for intangible assets, excluding goodwill, subject to amortization and intangible assets not subject to amortization:

| March 31, 2017 |  | June 30, 2016
Non-amortized intangible assets: |  |  |
Trademarks and tradenames (a) | $ | 426,372 |  |  | $ | 441,140 |
Amortized intangible assets: |  |  |
Other intangibles | 233,460 |  |  | 245,040 |
Less: accumulated amortization | (92,407 | ) |  | (81,393 | )
Net carrying amount | $ | 567,425 |  |  | $ | 604,787 |

(a) The gross carrying value of trademarks and tradenames is reflected net of $46,123 of accumulated impairment charges.
Indefinite-lived intangible assets, which are not amortized, consist primarily of acquired trade names and trademarks. Indefinite-lived intangible assets are evaluated on an annual basis, in conjunction with the Company’s evaluation of goodwill. In assessing fair value, the Company utilizes a “relief from royalty” methodology. This approach involves two steps: (i) estimating the royalty
19

Table of Contents
rates for each trademark and (ii) applying these royalty rates to a projected net sales stream and discounting the resulting cash flows to determine fair value. If the carrying value of the indefinite-lived intangible assets exceeds the fair value of the asset, the carrying value is written down to fair value in the period identified. The result of this assessment indicated that the fair value of certain of the Company’s tradenames was below their carrying value, and therefore an impairment charge of $39,724 ($20,932 in the United Kingdom segment and $18,792 in the United States segment) was recognized during the fiscal year ended June 30, 2016. There were no other impairment charges recorded during fiscal 2016, and no impairment charges were recorded during the nine months ended March 31, 2017.
Amortizable intangible assets, which are deemed to have a finite life, primarily consist of customer relationships and are being amortized over their estimated useful lives of 3 to 25 years. Amortization expense included in continuing operations was as follows:

| Three Months Ended March 31, |  | Nine Months Ended March 31,
| 2017 |  | 2016 |  | 2017 |  | 2016
Amortization of intangible assets | $ | 4,543 |  |  | $ | 4,553 |  |  | $ | 13,964 |  |  | $ | 13,896 |

20

Table of Contents
9. DEBT AND BORROWINGS
Debt and borrowings consisted of the following:

| March 31, 2017 |  | June 30, 2016
Credit Agreement borrowings payable to banks | $ | 774,415 |  |  | $ | 827,860 |
Tilda short-term borrowing arrangements | 8,225 |  |  | 19,121 |
Other borrowings | 6,685 |  |  | 15,703 |
| 789,325 |  |  | 862,684 |
Short-term borrowings and current portion of long-term debt | 8,457 |  |  | 26,513 |
| $ | 780,868 |  |  | $ | 836,171 |

Credit Agreement
On December 12, 2014, the Company entered into the Second Amended and Restated Credit Agreement (the “Credit Agreement”) which provides for a $1,000,000 unsecured revolving credit facility which may be increased by an additional uncommitted $350,000, provided certain conditions are met. The Credit Agreement expires in December 2019. Borrowings under the Credit Agreement may be used to provide working capital, finance capital expenditures and permitted acquisitions, refinance certain existing indebtedness and for other lawful corporate purposes. The Credit Agreement provides for multicurrency borrowings in Euros, Pounds Sterling and Canadian Dollars as well as other currencies which may be designated. In addition, certain wholly-owned foreign subsidiaries of the Company may be designated as co-borrowers. The Credit Agreement contains restrictive covenants usual and customary for facilities of its type, which include, with specified exceptions, limitations on the Company’s ability to engage in certain business activities, incur debt, have liens, make capital expenditures, pay dividends or make other distributions, enter into affiliate transactions, consolidate, merge or acquire or dispose of assets, and make certain investments, acquisitions and loans. The Credit Agreement also requires the Company to satisfy certain financial covenants, such as maintaining a consolidated interest coverage ratio (as defined in the Credit Agreement) of no less than 4.0 to 1.0 and a consolidated leverage ratio (as defined in the Credit Agreement) of no more than 3.5 to 1.0. The consolidated leverage ratio is subject to a step-up to 4.0 to 1.0 for the four full fiscal quarters following an acquisition. Obligations under the Credit Agreement are guaranteed by certain existing and future domestic subsidiaries of the Company. As of March 31, 2017, there were $774,415 of borrowings and $6,180 letters of credit outstanding under the Credit Agreement and $219,405 available. The Company was deemed to be in compliance with all associated covenants due to certain limited waivers and extensions received by the Company in connection with its obligation to deliver financial information.
The Credit Agreement provides that loans will bear interest at rates based on (a) the Eurocurrency Rate, as defined in the Credit Agreement, plus a rate ranging from 0.875% to 1.70% per annum; or (b) the Base Rate, as defined in the Credit Agreement, plus a rate ranging from 0.00% to 0.70% per annum, the relevant rate being the Applicable Rate. The Applicable Rate will be determined in accordance with a leverage-based pricing grid, as set forth in the Credit Agreement. Swing line loans and Global Swing Line loans denominated in U.S. dollars will bear interest at the Base Rate plus the Applicable Rate and Global Swing Line loans denominated in foreign currencies shall bear interest based on the overnight Eurocurrency Rate for loans denominated in such currency plus the Applicable Rate. The weighted average interest rate on outstanding borrowings under the Credit Agreement at March 31, 2017 was 2.24%. Additionally, the Credit Agreement contains a Commitment Fee, as defined in the Credit Agreement, on the amount unused under the Credit Agreement ranging from 0.20% to 0.30% per annum. Such Commitment Fee is determined in accordance with a leverage-based pricing grid, as set forth in the Credit Agreement.
Tilda Short-Term Borrowing Arrangements
Tilda maintains short-term borrowing arrangements primarily used to fund the purchase of rice from India and other countries. The maximum borrowings permitted under all such arrangements are £52,000. Outstanding borrowings are collateralized by the current assets of Tilda, typically have six-month terms and bear interest at variable rates typically based on LIBOR plus a margin (weighted average interest rate of approximately 3.2% at March 31, 2017).
21

Table of Contents
Other Borrowings
Other borrowings primarily relate to a cash pool facility in Europe. The cash pool facility provides our Europe operating segment with sufficient liquidity to support the Company’s growth objectives within this segment. The maximum borrowings permitted under the cash pool arrangement are €12,500. Outstanding borrowings bear interest at variable rates typically based on EURIBOR plus a margin of 1.1% (weighted average interest rate of approximately 1.1% at March 31, 2017).
10. INCOME TAXES
The Company uses an estimated annual effective tax rate, which is based on expected annual income and statutory tax rates in the various jurisdictions in which the Company operates, to determine its quarterly provision for income taxes. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rates from quarter to quarter. The Company’s effective tax rate may change from period to period based on recurring and non-recurring factors including the geographical mix of earnings, enacted tax legislation, state and local income taxes and tax audit settlements.
The effective income tax rate from continuing operations was 20.4% and 32.8% for the three months ended March 31, 2017 and 2016, respectively, and 22.4% and 30.5% for the nine months ended March 31, 2017 and 2016, respectively. The effective tax rate for the three and nine months ended March 31, 2017 was favorably impacted by the geographical mix of earnings and a reduction in the statutory tax rate in the United Kingdom enacted in the first quarter of fiscal 2017 resulting in a $2,086 decrease to the carrying value of the net deferred tax liabilities. The effective tax rate for the three and nine months ended March 31, 2017 was also favorably impacted by a $3,536 benefit relating to the release of a portion of the Company’s uncertain tax positions as a result of the expiration of the statute of limitations.
11. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
The following tables present the changes in accumulated other comprehensive income (loss):

| Three Months Ended March 31, |  | Nine Months Ended March 31,
| 2017 |  | 2016 |  | 2017 |  | 2016
Foreign currency translation adjustments: |  |  |  |  |  |  |
Other comprehensive (loss) before reclassifications (1) | $ | 14,630 |  |  | $ | (20,103 | ) |  | $ | (68,329 | ) |  | $ | (85,690 | )
Deferred gains/(losses) on cash flow hedging instruments: |  |  |  |  |  |  |
Other comprehensive income before reclassifications | 2 |  |  | 753 |  |  | 103 |  |  | 4,024 |
Amounts reclassified into income (2) | (19 | ) |  | (1,962 | ) |  | (525 | ) |  | (4,188 | )
Unrealized gain/(loss) on available for sale investment: |  |  |  |  |  |  |
Other comprehensive income (loss) before reclassifications | 47 |  |  | 20 |  |  | (22 | ) |  | (112 | )
Amounts reclassified into income (3) | 3 |  |  | — |  |  | 13 |  |  | — |
Net change in accumulated other comprehensive income (loss) | $ | 14,663 |  |  | $ | (21,292 | ) |  | $ | (68,760 | ) |  | $ | (85,966 | )

(1) | Foreign currency translation adjustments included intra-entity foreign currency transactions that were of a long-term investment nature of $(2,017) and $20,272 for the three months ended March 31, 2017 and 2016, respectively, and $18,043 and $62,083 for the nine months ended March 31, 2017 and 2016, respectively.

(2) | Amounts reclassified into income for deferred gains/(losses) on cash flow hedging instruments are recorded in “Cost of sales” in the Consolidated Statements of Income and, before taxes, were $23 and $2,546 for the three months ended March 31, 2017 and 2016, respectively and $1,173 and $5,492 for the nine months ended March 31, 2017 and 2016, respectively.

(3) | Amounts reclassified into income for gains on sale of available for sale investments were based on the average cost of the shares held (See Note 13, Investments and Joint Ventures). Such amounts are recorded in “Other (income)/expense, net” in the Consolidated Statements of Income and were $5 and $21 before taxes for the three and nine months ended March 31, 2017, respectively. There were no amounts reclassified into income for the three and nine months ended March 31, 2016.

22

Table of Contents
12. STOCK BASED COMPENSATION AND INCENTIVE PERFORMANCE PLANS
The Company has two shareholder-approved plans, the Amended and Restated 2002 Long-Term Incentive and Stock Award Plan and the 2000 Directors Stock Plan, under which the Company’s officers, senior management, other key employees, consultants and directors may be granted options to purchase the Company’s common stock or other forms of equity-based awards.
Compensation cost and related income tax benefits recognized in the Consolidated Statements of Income for stock based compensation plans were as follows:

| Three Months Ended March 31, |  | Nine Months Ended March 31,
| 2017 |  | 2016 |  | 2017 |  | 2016
Compensation cost (included in selling, general and administrative expense) | $ | 2,284 |  |  | $ | 2,776 |  |  | $ | 7,519 |  |  | $ | 10,005 |
Related income tax benefit | $ | 857 |  |  | $ | 1,041 |  |  | $ | 2,820 |  |  | $ | 3,752 |

Stock Options
A summary of the stock option activity for the nine months ended March 31, 2017 is as follows:

| Number of Options |  | Weighted Average Exercise Price |  | Weighted Average Contractual Life (years) |  | Aggregate Intrinsic Value
Options outstanding and exercisable at June 30, 2016 | 342 |  |  | $ | 6.66 |  |  |  |  |
Exercised | (220 | ) |  | $ | 9.10 |  |  |  |  |
Options outstanding and exercisable at March 31, 2017 | 122 |  |  | $ | 2.26 |  |  | 14.3 years |  | $ | 4,261 |

| Nine Months Ended March 31,
| 2017 |  | 2016
Intrinsic value of options exercised | $ | 6,507 |  |  | $ | 27,147 |
Tax benefit recognized from stock option exercises | $ | 2,538 |  |  | $ | 10,587 |

At March 31, 2017, there was no unrecognized compensation expense related to stock option awards.
Restricted Stock
A summary of the restricted stock and restricted share units activity for the nine months ended March 31, 2017 is as follows:

| Number of Shares and Units |  | Weighted Average Grant Date Fair Value (per share)
Non-vested restricted stock, restricted share units, and performance units at June 30, 2016 | 1,121 |  |  | $ | 28.24 |
Vested | (270 | ) |  | $ | 32.47 |
Forfeited | (21 | ) |  | $ | 32.77 |
Non-vested restricted stock, restricted share units, and performance units at March 31, 2017 | 830 |  |  | $ | 27.20 |

| Nine Months Ended March 31,
| 2017 |  | 2016
Fair value of restricted stock, restricted share units, and performance units granted | $ | — |  |  | $ | 9,947 |
Fair value of shares vested | $ | 9,101 |  |  | $ | 17,904 |
Tax benefit recognized from restricted shares vesting | $ | 3,502 |  |  | $ | 6,762 |

23

Table of Contents
On July 3, 2012, the Company entered into a Restricted Stock Agreement (the “Agreement”) with Irwin D. Simon, the Company’s Chairman, President and Chief Executive Officer. The Agreement provides for a grant of 800 shares of restricted stock (the “Shares”), the vesting of which is both market and time-based. The market condition is satisfied in increments of 200 Shares upon the Company’s common stock achieving four share price targets. On the last day of any forty-five consecutive trading day period during which the average closing price of the Company’s common stock on the Nasdaq Global Select Market equals or exceeds the following prices: $31.25, $36.25, $41.25 and $50.00, respectively, the market condition for each increment of 200 Shares will be satisfied. The market conditions must be satisfied prior to June 30, 2017. Once each market condition has been satisfied, a tranche of 200 Shares will vest in equal amounts annually over a five-year period. Except in the case of a change of control, termination without cause, death or disability (each as defined in Mr. Simon’s Employment Agreement), the unvested Shares are subject to forfeiture unless Mr. Simon remains employed through the applicable market and time vesting periods. The grant date fair value for each tranche was separately estimated based on a Monte Carlo simulation that calculated the likelihood of goal attainment and the time frame most likely for goal attainment. The total grant date fair value of the Shares was estimated to be $16,151, which was expected to be recognized over a weighted-average period of approximately 4.0 years. On September 28, 2012, August 27, 2013, December 13, 2013 and October 22, 2014, the four respective market conditions were satisfied. As such, the four tranches of 200 Shares are expected to vest in equal amounts over the five-year period commencing on the first anniversary of the date the market condition for the respective tranche was satisfied.
At March 31, 2017, $8,287 of unrecognized stock-based compensation expense, net of estimated forfeitures, related to non-vested restricted stock awards, inclusive of the Shares, was expected to be recognized over a weighted-average period of approximately 1.1 years.
Long-Term Incentive Plan
The Company maintains a long-term incentive program (the “LTI Plan”). The LTI Plan currently consists of a two-year performance-based long-term incentive plan (the “2015-2016 LTIP”) and a three-year performance-based long-term incentive plan (the “2016-2018 LTIP”) that provide for a combination of equity grants and performance awards that can be earned over the respective performance period. Participants in the LTI Plan include the Company’s executive officers, including the Chief Executive Officer, and certain other key executives.
The Compensation Committee administers the LTI Plan and is responsible for, among other items, establishing the target values of awards to participants and selecting the specific performance factors for such awards. The Compensation Committee determines the specific payout to the participants. Such awards may be paid in cash and/or unrestricted shares of the Company’s common stock at the discretion of the Compensation Committee, provided that any such stock-based awards shall be issued pursuant to and be subject to the terms and conditions of the Amended and Restated 2002 Long-Term Incentive and Stock Award Plan, as in effect and as amended from time to time.
Upon the adoption of the 2015-2016 LTIP, the Compensation Committee granted an initial award to each participant in the form of equity-based instruments (restricted stock or restricted share units), for a portion of the individual target awards (the “Initial Equity Grants”). These Initial Equity Grants are subject to time vesting requirements, and a portion are also subject to the achievement of minimum performance goals. The 2015-2016 LTIP awards contain an additional year of time-based vesting. The Initial Equity Grants are expensed over the respective vesting periods on a straight-line basis. The payment of the actual awards earned at the end of the applicable performance period, if any, will be reduced by the value of the Initial Equity Grants.
Upon adoption of the 2016-2018 LTIP, the Compensation Committee granted performance units to each participant, the achievement of which is dependent upon a defined calculation of relative total shareholder return over the period from July 1, 2015 to June 30, 2018 (the “TSR Grant”). The grant date fair value for these awards was separately estimated based on a Monte Carlo simulation that calculated the likelihood of goal attainment. Each performance unit translates into one unit of common stock. The TSR grant represents half of each participant’s target award. The other half of the 2016-2018 LTIP is based on the Company’s achievement of specified net sales growth targets over this three-year period and, if achieved, may be paid in cash and/or unrestricted shares of the Company’s common stock at the discretion of the Compensation Committee.
The Company has recorded expense (in addition to the stock based compensation expense associated with the Initial Equity Grants and the TSR Grant) of $1,127 and $3,382 for the three and nine months ended March 31, 2017, respectively, due to the Company’s current estimates of achievement under the plans. The Company recorded expense of $1,127 and $4,290 for the three and nine months ended March 31, 2016, respectively, related to the LTI Plan.
24

Table of Contents
13. INVESTMENTS AND JOINT VENTURES
Equity method investments
In October 2009, the Company formed a joint venture, Hutchison Hain Organic Holdings Limited (“HHO”), with Hutchison China Meditech Ltd. (“Chi-Med”), a majority-owned subsidiary of CK Hutchison Holdings Limited, to market and distribute certain of the Company’s brands in Hong Kong, China and other surrounding markets. Voting control of the joint venture is shared equally between the Company and Chi-Med, although, in the event of a deadlock, Chi-Med has the ability to cast the deciding vote, and therefore the investment is being accounted for under the equity method of accounting. At March 31, 2017 and June 30, 2016, the carrying value of the Company’s 50.0% investment in and advances to HHO were $1,267 and $1,729, respectively, and are included in the Consolidated Balance Sheet as a component of “Investments and joint ventures.”
On October 27, 2015, the Company acquired a 14.9% interest in Chop’t Creative Salad Company LLC (“Chop’t”). Chop’t develops and operates fast-casual, fresh salad restaurants in the Northeast and Mid-Atlantic United States. Chop’t markets and sells certain of the Company’s branded products and provides consumer insight and feedback. The investment is being accounted for as an equity method investment due to the Company’s representation on the Board of Directors. At March 31, 2017 and June 30, 2016, the carrying value of the Company’s investment in Chop’t was $16,780 and $17,448, respectively, and is included in the Consolidated Balance Sheet as a component of “Investments and joint ventures.” The Company’s current ownership percentage may be diluted in the future to 12.1%, pending the distribution of additional ownership interests.
Available-For-Sale Securities
The Company has a less than 1% equity ownership interest in Yeo Hiap Seng Limited (“YHS”), a Singapore-based natural food and beverage company listed on the Singapore Exchange, which is accounted for as an available-for-sale security. The Company sold 21 and 102 of its YHS shares during the three and nine months ended March 31, 2017, respectively, which resulted in a pre-tax loss of $5 and $21 on the sales, respectively, and recognized as a component of “Other (income)/expense, net.” No shares were sold during the three and nine months ended March 31, 2016. The remaining shares held at March 31, 2017 totaled 933. The fair value of these shares held was $929 (cost basis of $1,164) at March 31, 2017 and $1,067 (cost basis of $1,291) at June 30, 2016 and is included in “Investments and joint ventures,” with the related unrealized gain or loss, net of tax, included in “Accumulated other comprehensive loss” in the Consolidated Balance Sheet. The company concluded that the decline in its YHS investment below its cost basis is temporary and, accordingly, has not recognized a loss in the Consolidated Statements of Operations. In making this determination, the company considered its intent and ability to hold the investment until the cost is recovered, the financial condition and near-term prospects of YHS, the magnitude of the loss compared to the investment’s cost, and publicly available information about the industry and geographic region in which YHS operates.
25

Table of Contents
14. FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE
The Company’s financial assets and liabilities measured at fair value are required to be grouped in one of three levels. The levels prioritize the inputs used to measure the fair value of the assets or liabilities. These levels are:

• | Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

• | Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and

• | Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

The following table presents by level within the fair value hierarchy assets and liabilities measured at fair value on a recurring basis as of March 31, 2017:

| Total |  | Quoted prices in active markets (Level 1) |  | Significant other observable inputs (Level 2) |  | Significant unobservable inputs (Level 3)
Assets: |  |  |  |  |  |  |
Cash equivalents | $ | 45,043 |  |  | $ | 45,043 |  |  | $ | — |  |  | $ | — |
Forward foreign currency contracts | 31 |  |  | — |  |  | 31 |  |  | — |
Available for sale securities | 929 |  |  | — |  |  | 929 |  |  | — |
| $ | 46,003 |  |  | $ | 45,043 |  |  | $ | 960 |  |  | $ | — |
Liabilities: |  |  |  |  |  |  |
Contingent consideration, current | $ | 1,584 |  |  | $ | — |  |  | $ | — |  |  | $ | 1,584 |
Total | $ | 1,584 |  |  | $ | — |  |  | $ | — |  |  | $ | 1,584 |

The following table presents by level within the fair value hierarchy assets and liabilities measured at fair value on a recurring basis as of June 30, 2016:

| Total |  | Quoted prices in active markets (Level 1) |  | Significant other observable inputs (Level 2) |  | Significant unobservable inputs (Level 3)
Assets: |  |  |  |  |  |  |
Cash equivalents | $ | 20,706 |  |  | $ | 20,706 |  |  | $ | — |  |  | $ | — |
Forward foreign currency contracts | 531 |  |  | — |  |  | 531 |  |  | — |
Available for sale securities | 1,067 |  |  | 1,067 |  |  | — |  |  | — |
| $ | 22,304 |  |  | $ | 21,773 |  |  | $ | 531 |  |  | $ | — |
Liabilities: |  |  |  |  |  |  |
Contingent consideration, current | $ | 3,553 |  |  | $ | — |  |  | $ | — |  |  | $ | 3,553 |
Total | $ | 3,553 |  |  | $ | — |  |  | $ | — |  |  | $ | 3,553 |

Available for sale securities consist of the Company’s investment in YHS (see Note 13, Investments and Joint Ventures). Fair value is measured using the market approach based on quoted prices. The Company utilizes the income approach to measure fair value for its foreign currency forward contracts. The income approach uses pricing models that rely on market observable inputs such as yield curves, currency exchange rates and forward prices.
26

Table of Contents
The Company estimates the original fair value of the contingent consideration as the present value of the expected contingent payments, determined using the weighted probabilities of the possible payments. The Company reassesses the fair value of contingent payments on a periodic basis. Although the Company believes that its estimated and assumptions are reasonable, different assumptions, including those regarding the operating results of the respective businesses, or changes in the future may result in different estimated amounts. At March 31, 2017, contingent consideration of $1,584 was included in “Accrued expenses and other current liabilities” in the Company’s Consolidated Balance Sheet in connection with the acquisition of Belvedere International, Inc. in February 2015.
The following table summarizes the Level 3 activity for the nine months ended March 31, 2017.

Balance as of June 30, 2016 | $ | 3,553 |
Contingent consideration adjustment and accretion of interest expense, net | 526 |
Contingent consideration paid (a) | (2,498 | )
Translation adjustment | 3 |
Balance as of March 31, 2017 | $ | 1,584 |

(a) Contingent consideration payment relates to the acquisition of Orchard House completed in December 2015. See
Note 5, Acquisitions.
There were no transfers of financial instruments between the three levels of fair value hierarchy during the nine months ended March 31, 2017 or 2016.
The carrying amount of cash and cash equivalents, accounts receivable, net, accounts payable and certain accrued expenses and other current liabilities approximate fair value due to the short-term maturities of these financial instruments. The Company’s debt approximates fair value due to the debt bearing fluctuating market interest rates (See Note 9, Debt and Borrowings).
Derivative Instruments
The Company primarily has exposure to changes in foreign currency exchange rates relating to certain anticipated cash flows from its international operations. To reduce that risk, the Company may enter into certain derivative financial instruments, when available on a cost-effective basis, to manage such risk. Derivative financial instruments are not used for speculative purposes.
The Company utilizes foreign currency contracts to hedge forecasted transactions, including intercompany transactions, on certain foreign currencies and designates these derivative instruments as foreign currency cash flow hedges when appropriate. The Company also occasionally enters into fair value hedges to mitigate its foreign currency risk related to certain firm commitments. The notional and fair value amounts of the Company’s foreign exchange derivative contracts outstanding at March 31, 2017 were $1,602 and $31 of net assets, respectively. There were $6,000 of notional amount and $531 of net assets of foreign exchange derivative contracts outstanding at June 30, 2016. The fair value of these derivatives is included in prepaid expenses and other current assets and accrued expenses and other current liabilities in the Consolidated Balance Sheet. For these derivatives, which qualify as hedges of probable forecasted cash flows, the effective portion of changes in fair value is temporarily reported in accumulated other comprehensive income and recognized in earnings when the hedged item affects earnings. These foreign exchange contracts have maturities over the next six months.
The Company assesses effectiveness at the inception of the hedge and on a quarterly basis. These assessments determine whether derivatives designated as qualifying hedges continue to be highly effective in offsetting changes in the cash flows of hedged items. Any ineffective portion of change in fair value is not deferred in accumulated other comprehensive income and is included in current period results. For the three and nine months ended March 31, 2017 and 2016, the impact of hedge ineffectiveness on earnings was not significant. The Company will discontinue cash flow hedge accounting when the forecasted transaction is no longer probable of occurring on the originally forecasted date or when the hedge is no longer effective. There were no discontinued foreign exchange hedges for the three and nine months ended March 31, 2017 and 2016.
15. COMMITMENTS AND CONTINGENCIES
Securities Class Actions Filed in Federal Court
On August 17, 2016, three securities class action complaints were filed in the Eastern District of New York against the Company alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The three complaints are: (1) Flora v. The
27

Table of Contents
Hain Celestial Group, Inc., et al., (the “Flora Complaint”); (2) Lynn v. the Hain Celestial Group, Inc., et al. (the “Lynn Complaint”); and (3) Spadola v. The Hain Celestial Group, Inc., et al. (the “Spadola Complaint” and, together with the Flora and Lynn Complaints, the “Securities Complaints”). The Securities Complaints allege that the Company and certain of its officers made materially false and misleading statements in press releases and SEC filings regarding the Company’s business, prospects and financial results. The Securities Complaints were brought on behalf of all persons who purchased or otherwise acquired Hain securities between November 5, 2015 and August 15, 2016. On October 17, 2016, six potential plaintiffs and their respective law firms moved to serve as lead plaintiff and counsel. On June 5, 2017, the Court issued an order for consolidation, appointment of Co-Lead Plaintiffs and approval of selection of co-lead counsel. Pursuant to this order, the Securities Complaints were consolidated under the caption In re The Hain Celestial Group, Inc. Securities Litigation, and Rosewood Funeral Home and Salamon Gimpel were appointed as Co-Lead Plaintiffs.
Stockholder Derivative Complaints Filed in State Court
On September 16, 2016, a stockholder derivative complaint, Paperny v. Heyer, et al. (the “Paperny Complaint”), was filed in New York State Supreme Court in Nassau County against the Board of Directors and certain officers of the Company alleging breach of fiduciary duty, unjust enrichment, lack of oversight and corporate waste. On December 2, 2016 and December 29, 2016, two additional stockholder derivative complaints were filed in New York State Supreme Court in Nassau County against the Board of Directors and certain officers under the captions Scarola v. Simon (the “Scarola Complaint”) and Shakir v. Simon (the “Shakir Complaint” and, together with the Paperny Complaint and the Scarola Complaint, the “Derivative Complaints”), respectively. Both the Scarola Complaint and the Shakir Complaint allege breach of fiduciary duty, lack of oversight and unjust enrichment. On February 16, 2017, the parties for the Derivative Complaints entered into a stipulation consolidating the matters under the caption In re The Hain Celestial Group (the “Consolidated Derivative Action”) in New York State Supreme Court in Nassau County, and the parties agreed to stay the Consolidated Derivative Action until November 2, 2017.
Additional Stockholder Class Action and Derivative Complaints Filed in Federal Court
On April 19, 2017 and April 26, 2017, two class action and stockholder derivative complaints were filed in the Eastern District of New York against the Board of Directors and certain officers of the Company under the captions Silva v. Simon, et al. (the “Silva Complaint”) and Barnes v. Simon, et al. (the “Barnes Complaint”), respectively. Both the Silva Complaint and the Barnes Complaint allege violation of securities law, breach of fiduciary duty, waste of corporate assets and unjust enrichment.
On May 23, 2017, an additional stockholder filed a complaint under seal in the Eastern District of New York against the Board of Directors and certain officers of the Company. The complaint alleges that the Company’s directors and certain officers made materially false and misleading statements in press releases and SEC filings regarding the Company’s business, prospects and financial results. The complaint also alleges that the Company violated its by-laws and Delaware law by failing to hold an Annual Stockholders Meeting and includes claims for breach of fiduciary duty, unjust enrichment and corporate waste.
SEC Investigation
As previously disclosed, the Company voluntarily contacted the SEC in August 2016 to advise it of the Company’s delay in the filing of its periodic reports and the performance of the independent review conducted by the Audit Committee. The Company has continued to provide information to the SEC on an ongoing basis, including, among other things, the results of the independent review of the Audit Committee as well as other information pertaining to its internal accounting review relating to revenue recognition. On January 31, 2017, the SEC issued a subpoena to the Company seeking documents relevant to its investigation. The Company is in the process of responding to the SEC’s requests for information and intends to cooperate fully with the SEC.
Other
In addition to the litigation described above, the Company is and may be a defendant in lawsuits from time to time in the normal course of business. While the results of litigation and claims cannot be predicted with certainty, the Company believes the reasonably possible losses of such matters, individually and in the aggregate, are not material. Additionally, the Company believes the probable final outcome of such matters will not have a material adverse effect on the Company’s consolidated results of operations, financial position, cash flows or liquidity.
28

Table of Contents
16. SEGMENT INFORMATION
Prior to July 1, 2016, the Company’s operations were managed in seven operating segments: the United States, United Kingdom, Tilda, Hain Pure Protein Corporation (“HPPC”), EK Holdings, Inc. (“Empire”), Canada and Europe. The United States operating segment was also a reportable segment. The United Kingdom and Tilda operating segments were reported in the aggregate as “United Kingdom”, while HPPC and Empire were reported in the aggregate as “Hain Pure Protein,” and Canada and Europe were combined and reported as “Rest of World.”
Effective July 1, 2016, due to changes to the Company’s internal management and reporting structure resulting from the formation of Cultivate, certain brands previously included within the United States operating segment were moved to a new operating segment called Cultivate. As a result, the Company is now managed in eight operating segments: the United States (excluding Cultivate), United Kingdom, Tilda, HPPC, Empire, Canada, Europe and Cultivate. The United States, excluding Cultivate, is its own reportable segment. Cultivate is now combined with Canada and Europe and reported within the “Rest of World” reportable segment. There were no changes to the United Kingdom and Hain Pure Protein reportable segments. The prior period segment information contained below has been adjusted to reflect the Company’s new operating and reporting structure. See Note 1, Business, for additional details surrounding the formation of Cultivate.
Net sales and operating income are the primary measures used by the Company’s Chief Operating Decision Maker (“CODM”) to evaluate segment operating performance and to decide how to allocate resources to segments. The CODM is the Company’s Chief Executive Officer. Expenses related to certain centralized administration functions that are not specifically related to an operating segment are included in “Corporate and Other.” Corporate and Other expenses are comprised mainly of the compensation and related expenses of certain of the Company’s senior executive officers and other selected employees who perform duties related to the entire enterprise, as well as expenses for certain professional fees, facilities, and other items which benefit the Company as a whole. Additionally, acquisition related expenses, restructuring and integration charges and other, along with accounting review costs are included in “Corporate and Other.” Expenses that are managed centrally but can be attributed to a segment, such as employee benefits and certain facility costs, are allocated based on reasonable allocation methods. Assets are reviewed by the CODM on a consolidated basis and therefore are not reported by operating segment.
The following tables set forth financial information about each of the Company’s reportable segments. Transactions between reportable segments were insignificant for all periods presented.

| Three Months Ended March 31, |  | Nine Months Ended March 31,
| 2017 |  | 2016 |  | 2017 |  | 2016
Net Sales: |  |  |  |  |  |  |
United States | $ | 308,539 |  |  | $ | 325,384 |  |  | $ | 882,273 |  |  | $ | 942,700 |
United Kingdom | 181,940 |  |  | 206,160 |  |  | 573,541 |  |  | 558,269 |
Hain Pure Protein | 117,765 |  |  | 112,213 |  |  | 387,413 |  |  | 379,459 |
Rest of World | 98,319 |  |  | 92,906 |  |  | 284,799 |  |  | 267,399 |
| $ | 706,563 |  |  | $ | 736,663 |  |  | $ | 2,128,026 |  |  | $ | 2,147,827 |
Operating Income: |  |  |  |  |  |  |
United States | $ | 46,838 |  |  | $ | 56,381 |  |  | $ | 111,453 |  |  | $ | 148,828 |
United Kingdom | 11,545 |  |  | 15,826 |  |  | 22,792 |  |  | 44,093 |
Hain Pure Protein | (2,554 | ) |  | 2,427 |  |  | (31 | ) |  | 31,078 |
Rest of World | 9,362 |  |  | 8,132 |  |  | 21,894 |  |  | 17,646 |
| $ | 65,191 |  |  | $ | 82,766 |  |  | $ | 156,108 |  |  | $ | 241,645 |
Corporate and Other (1) | (18,124 | ) |  | (11,618 | ) |  | (53,890 | ) |  | (26,147 | )
| $ | 47,067 |  |  | $ | 71,148 |  |  | $ | 102,218 |  |  | $ | 215,498 |

(1) | Includes $9,207 and $5,317 of accounting review costs and acquisition related expenses, restructuring and integration charges and other for the three months ended March 31, 2017 and 2016, respectively. Such expenses for the nine months ended March 31, 2017 and 2016 were $22,741 and $9,909, respectively.

29

Table of Contents
The Company’s long-lived assets, which primarily represent net property, plant and equipment, by geographic area are as follows:

| March 31, 2017 |  | June 30, 2016
United States | $ | 195,605 |  |  | $ | 193,192 |
United Kingdom | 178,074 |  |  | 196,271 |
All Other | 54,848 |  |  | 53,260 |
| $ | 428,527 |  |  | $ | 442,723 |

The Company’s net sales by geographic region, which are generally based on the location of the Company’s subsidiary, are as follows:

| Three Months Ended March 31, |  | Nine Months Ended March 31,
| 2017 |  | 2016 |  | 2017 |  | 2016
United States | $ | 423,360 |  |  | $ | 436,110 |  |  | $ | 1,255,539 |  |  | $ | 1,314,620 |
United Kingdom | 200,976 |  |  | 226,267 |  |  | 633,439 |  |  | 619,798 |
All Other | 82,227 |  |  | 74,286 |  |  | 239,048 |  |  | 213,409 |
Total | $ | 706,563 |  |  | $ | 736,663 |  |  | $ | 2,128,026 |  |  | $ | 2,147,827 |

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
This Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the March 31, 2017 Consolidated Financial Statements and the related Notes thereto contained in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K for the fiscal year ended June 30, 2016. Forward looking statements in this Form 10-Q are qualified by the cautionary statement included in this Form 10-Q under the sub-heading “Cautionary Note Regarding Forward Looking Information” in the introduction of this Form 10-Q.
Revisions of Consolidated Financial Statements
As previously reported, we were unable to timely file our Annual Report on Form 10-K for our fiscal year ended June 30, 2016 (the “Form 10-K”) and our Quarterly Reports on Form 10-Q for the quarters ended September 30, 2016 (the “Q1 Form 10-Q”), December 31, 2016 (the “Q2 Form 10-Q”), and March 31, 2017 (the “Form 10-Q”). During the fourth quarter of fiscal 2016, the Company identified the practice of granting additional concessions to certain distributors in the United States and commenced an internal accounting review in order to (i) determine whether the revenue associated with those concessions was accounted for in the correct period and (ii) evaluate the Company’s internal control over financial reporting. The Audit Committee of the Company’s Board of Directors separately conducted an independent review of these matters and retained independent counsel to assist in their review. We delayed the filing of this Form 10-Q and our Form 10-K, Q1 Form 10-Q and Q2 Form 10-Q with the SEC in order to complete these reviews.
The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) reflects revisions to prior year balances due to corrections of the immaterial errors identified during these reviews. For a detailed discussion of the reviews and immaterial error corrections, see Explanatory Note on page 2 of this Form 10-Q and Note 3, Correction of Immaterial Errors to Prior Period Financial Statements, in the Notes to Consolidated Financial Statements included in Item 1 of this Form 10-Q.
Overview
The Hain Celestial Group, Inc., a Delaware corporation, and its subsidiaries (collectively, “Hain Celestial” or the “Company,” and herein referred to as “we,” “us,” and “our”) was founded in 1993 and is headquartered in Lake Success, New York. The Company’s mission has continued to evolve since its founding, with health and wellness being the core tenet — to be the leading marketer, manufacturer and seller of organic and natural, better-for-you products by anticipating and exceeding consumer expectations in providing quality, innovation, value and convenience. The Company is committed to growing sustainably while continuing to implement environmentally sound business practices and manufacturing processes. Hain Celestial sells its products through specialty and natural food distributors, supermarkets, natural food stores, mass-market and e-commerce retailers, food service channels and clubs, and drug and convenience stores in over 80 countries worldwide.
30

Table of Contents
With a proven track record of strategic growth and profitability, the Company manufactures, markets, distributes and sells organic and natural products under brand names that are sold as “better-for-you” products, providing consumers with the opportunity to lead A Healthier Way of LifeTM. Hain Celestial is a leader in many organic and natural products categories, with many recognized brands in the various market categories it serves, including Almond Dream®, Arrowhead Mills®, Bearitos®, BluePrint®, Celestial Seasonings®, Coconut Dream®, Cully & Sully®, Danival®, DeBoles®, Earth’s Best®, Ella’s Kitchen®, Empire®, Europe’s Best®, Farmhouse Fare®, Frank Cooper’s®, FreeBird®, Gale’s®, Garden of Eatin’®, GG UniqueFiberTM, Hain Pure Foods®, Hartley’s®, Health Valley®, Imagine®, Johnson’s Juice Co.®, Joya®, Kosher Valley®, Lima®, Linda McCartney’s® (under license), MaraNatha®, Natumi®, New Covent Garden Soup Co.®, Plainville Farms®, Rice Dream®, Robertson’s®, Rudi’s Gluten-Free Bakery®, Rudi’s Organic Bakery®, Sensible Portions®, Spectrum Organics®, Soy Dream®, Sun-Pat®, SunSpire®, Terra®, The Greek Gods®, Tilda®, WestSoy® and Yves Veggie Cuisine®. The Company’s personal care products are marketed under the Alba Botanica®, Avalon Organics®, Earth’s Best®, JASON®, Live Clean® and Queen Helene® brands.
Project Terra
During fiscal year 2016, the Company commenced a strategic review, which it called “Project Terra,” that resulted in the Company redefining its core platforms starting with the United States segment for future growth based upon consumer trends to create and inspire A Healthier Way of Life™. The core platforms are defined by common consumer need, route-to-market or internal advantage and are aligned with the Company’s strategic roadmap to continue its leadership position in the organic and natural, better-for-you products industry. Beginning in fiscal year 2017, those core platforms within the United States segment are:

• | Better-for-You-Baby, which includes infant foods, infant formula, diapers and wipe products that nurture and care for babies and toddlers, under the Earth’s Best® and Ella’s Kitchen® brands.

• | Better-for-You-Pantry, which include core consumer staples, such as Maranatha®, Arrowhead Mills®, Imagine® and Spectrum Organics® brands.

• | Better-for-You-Snacking, which include wholesome products for in-between meals, such as Terra®, Sensible Portions® and Garden of Eatin’® brands.

• | Fresh Living, which includes, yogurt, plant-based proteins and other refrigerated products, such as The Greek Gods® yogurt and Dream™ plant-based beverage brands.

• | Pure Personal Care, which includes personal care products focused on providing consumers with cleaner and gentler ingredients, such as JASON®, Avalon Organics®, and Alba Botanica® brands.

• | Tea, which includes tea products marketed under the Celestial Seasonings® brand.

In addition, beginning in fiscal 2017, the Company launched Cultivate Ventures (“Cultivate”), a venture unit with a threefold purpose: (i) to strategically invest in the Company’s smaller brands in high potential categories such as BluePrint® cold-pressed juices, SunSpire® chocolates and DeBoles® pasta by giving those products a dedicated, creative focus for refresh and relaunch; (ii) to incubate small acquisitions until they reach the scale for the Company’s core platforms; and (iii) to invest in concepts, products and technology that focus on health and wellness.
Another key initiative from Project Terra was the identification of global cost savings expected over the next three fiscal years, a portion of which the Company intends to reinvest into its brands. Additionally, the Company identified certain brands for divestment, which no longer fit into its core strategy for future growth. The disposal of these brands does not represent a strategic shift and is not expected to have a major effect on the Company's operations or financial results, as defined by ASC 205-20, Discontinued Operations; as a result, the disposals do not meet the criteria to be classified as discontinued operations.
Finally, in connection with Project Terra, the Company, with the assistance of outside consultants, engaged in an evaluation of its trade investment in the United States segment. Based on this assessment, the Company determined that its trade investment could be utilized more effectively, and therefore, beginning in fiscal 2017, the Company developed plans to shift from a model of investing in trade at the non-consumer facing level to more consumer facing activities.
Change in Segments
Prior to July 1, 2016, the Company’s operations were managed in seven operating segments: the United States, United Kingdom, Tilda, Hain Pure Protein Corporation (“HPPC”), EK Holdings, Inc. (“Empire”), Canada and Europe. The United States operating segment was also a reportable segment. The United Kingdom and Tilda operating segments were reported in the aggregate as “United Kingdom”, while HPPC and Empire were reported in the aggregate as “Hain Pure Protein,” and Canada and Europe were combined and reported as “Rest of World.”
Effective July 1, 2016, due to changes to the Company’s internal management and reporting structure resulting from the formation of Cultivate, certain brands previously included within the United States operating segment were moved to a new operating segment
31

Table of Contents
called Cultivate. As a result, the Company is now managed in eight operating segments: the United States (excluding Cultivate), United Kingdom, Tilda, HPPC, Empire, Canada, Europe and Cultivate. The United States, excluding Cultivate, is its own reportable segment. Cultivate is now combined with Canada and Europe and reported within the “Rest of World” reportable segment. There were no changes to the United Kingdom and Hain Pure Protein reportable segments. All prior period data throughout this MD&A has been adjusted to reflect the new operating and reporting structure. See Note 16, Segment Information, in the Notes to Consolidated Financial Statements included in Item 1 of this Form 10-Q for additional details.
Within each segment, our business strategy is to integrate our brands under one management team and employ uniform marketing, sales and distribution programs when attainable. We believe that, by integrating our various brands, we will continue to achieve economies of scale and enhanced market penetration. We seek to capitalize on the equity of our brands and the distribution achieved through each of our acquired businesses with strategic introductions of new products that complement existing lines to enhance revenues and margins.
32

Table of Contents
Results of Operations
Comparison of Three Months Ended March 31, 2017 to Three Months Ended March 31, 2016
Consolidated Results
The following table compares our results of operations, including as a percentage of net sales, on a consolidated basis, for the three months ended March 31, 2017 and 2016 (amounts in thousands, other than percentages which may not add due to rounding):

| Three Months Ended |  | Change in
| March 31, 2017 |  | March 31, 2016 |  | Dollars |  | Percentage
Net sales | $ | 706,563 |  |  | 100.0% |  | $ | 736,663 |  |  | 100.0% |  | $ | (30,100 | ) |  | (4.1)%
Cost of sales | 563,170 |  |  | 79.7% |  | 576,755 |  |  | 78.3% |  | (13,585 | ) |  | (2.4)%
Gross profit | 143,393 |  |  | 20.3% |  | 159,908 |  |  | 21.7% |  | (16,515 | ) |  | (10.3)%
Selling, general and administrative expenses | 82,576 |  |  | 11.7% |  | 78,890 |  |  | 10.7% |  | 3,686 |  |  | 4.7%
Amortization of acquired intangibles | 4,543 |  |  | 0.6% |  | 4,553 |  |  | 0.6% |  | (10 | ) |  | (0.2)%
Acquisition related expenses, restructuring and integration charges and other | 2,083 |  |  | 0.3% |  | 5,317 |  |  | 0.7% |  | (3,234 | ) |  | (60.8)%
Accounting review costs | 7,124 |  |  | 1.0% |  | — |  |  | — |  | 7,124 |  |  | n/a
Operating income | 47,067 |  |  | 6.7% |  | 71,148 |  |  | 9.7% |  | (24,081 | ) |  | (33.8)%
Interest and other financing expense, net | 5,439 |  |  | 0.8% |  | 6,920 |  |  | 0.9% |  | (1,481 | ) |  | (21.4)%
Other (income)/expense, net | 2,072 |  |  | 0.3% |  | 378 |  |  | 0.1% |  | 1,694 |  |  | 448.1%
Gain on fire insurance recovery | — |  |  | — |  | (9,013 | ) |  | (1.2)% |  | 9,013 |  |  | 100.0%
Income before income taxes and equity in net (income) loss of equity-method investees | 39,556 |  |  | 5.6% |  | 72,863 |  |  | 9.9% |  | (33,307 | ) |  | (45.7)%
Provision for income taxes | 8,051 |  |  | 1.1% |  | 23,914 |  |  | 3.2% |  | (15,863 | ) |  | (66.3)%
Equity in net (income) loss of equity-method investees | 177 |  |  | — |  | 161 |  |  | — |  | 16 |  |  | 9.9%
Net income | $ | 31,328 |  |  | 4.4% |  | $ | 48,788 |  |  | 6.6% |  | $ | (17,460 | ) |  | (35.8)%
Adjusted EBITDA | $ | 74,712 |  |  | 10.6% |  | $ | 98,103 |  |  | 13.3% |  | $ | (23,391 | ) |  | (23.8)%

Net Sales
Net sales for the three months ended March 31, 2017 were $706.6 million, a decrease of $30.1 million, or 4.1%, from net sales of $736.7 million for the three months ended March 31, 2016. Foreign currency exchange rates decreased net sales by $29.9 million as compared to the prior year quarter. On a constant currency basis, net sales were essentially flat from the prior year quarter. Net sales were adversely impacted by a realignment of customer inventories and stock-keeping unit (“SKU”) rationalizations in our United States segment, as well as increased trade spend and competitive pricing actions taken in all segments.
Gross Profit
Gross profit for the three months ended March 31, 2017 was $143.4 million, a decrease of $16.5 million, or 10.3%, as compared to the prior year quarter. Gross profit margin was 20.3% of sales, down 140 basis points from the prior year quarter. Gross profit was unfavorably impacted by price adjustments and customer sales mix in the United States, margin dilution from the acquisition of Orchard House, increased production costs in the United Kingdom, increased costs of purchases in non-functional currencies, and increased start-up costs in connection with our new FreeBird manufacturing facility at HPPC. Additionally, the prior year quarter was impacted by a supply shortage within poultry farms in the Midwest, which favorably impacted sales volume and pricing at HPPC. The decrease in gross profit was offset in part by increased sales and operating efficiencies at our plant-based manufacturing facilities in Europe.
Selling, General and Administrative Expenses
Selling, general and administrative expenses were $82.6 million, an increase of $3.7 million, or 4.7%, for the three months ended March 31, 2017 from $78.9 million for the prior year quarter. Foreign exchange rates resulted in decreased selling, general and
33

Table of Contents
administrative expenses of $2.7 million as compared to the prior year quarter. Selling, general and administrative expenses were impacted by additional marketing and advertising expenses in the United States and additional expense at HPPC primarily due to an increase in bad debt reserves as compared to the prior year quarter. Selling, general and administrative expenses as a percentage of net sales was 11.7% for the three months ended March 31, 2017 and 10.7% for the prior year quarter, an increase of 100 basis points primarily attributable to the aforementioned items.
Amortization of Acquired Intangibles
Amortization of acquired intangibles was $4.5 million in the three months ended March 31, 2017, a decrease of $0.01 million, or 0.2%, from $4.6 million for the prior year quarter. See Note 8, Goodwill and Other Intangibles, in the Notes to Consolidated Financial Statements included in Item 1 of this Form 10-Q.
Acquisition Related Expenses, Restructuring and Integration Charges and Other
Acquisition related expenses, restructuring and integration charges and other were $2.1 million in the three months ended March 31, 2017, which related to professional fees associated with the acquisitions of Orchard House in fiscal 2016 and The Yorkshire Provender Limited in the United Kingdom, which closed in the fourth quarter of fiscal 2017, consulting fees incurred in connection with our execution of Project Terra and severance charges with respect to the United States and Corporate.
Acquisition related expenses, restructuring and integration charges and other were $5.3 million in the three months ended March 31, 2016, which primarily related to additional contingent consideration expense for the Belvedere acquisition, severance costs related to a recently completed restructuring, most of which occurred in the United States, integration costs associated with the Orchard House acquisition and other professional fees.
Accounting Review Costs
Accounting review costs were $7.1 million in the three months ended March 31, 2017, which related to professional fees associated with our internal accounting review. See Explanatory Note on page 2 of this Form 10-Q and Note 3, Correction of Immaterial Errors to Prior Period Financial Statements, in the Notes to Consolidated Financial Statements included in Item 1 of this Form 10-Q for details.
Operating Income
Operating income for the three months ended March 31, 2017 was $47.1 million, a decrease of $24.1 million, or 33.8%, from $71.1 million for the three months ended March 31, 2016. Operating income as a percentage of net sales was 6.7% for the third quarter of fiscal 2016 compared with 9.7% in the prior year quarter. The decrease in operating income as a percentage of net sales resulted from the items described above.
Interest and Other Financing Expense, net
Interest and other financing expense, net totaled $5.4 million of expense for the three months ended March 31, 2017, a decrease of $1.5 million, or 21.4%, from $6.9 million of expense in the prior year. The decrease in interest and other financing expense, net resulted primarily from the conversion of our $150.0 million senior notes to our revolving credit facility in the fourth quarter of fiscal 2016. See Note 9, Debt and Borrowings, in the Notes to Consolidated Financial Statements included in Item 1 of this Form 10-Q.
Other (Income)/Expense, net
Other (income)/expense, net totaled $2.1 million for the three months ended March 31, 2017, an increase of $1.7 million, or 448.1% from $0.4 million of income for the prior year quarter. Included in other (income)/expense, net are net unrealized foreign currency losses, which were lower in the current quarter than the prior year quarter principally due to the effect of foreign currency movements on the remeasurement of foreign currency denominated intercompany loans.
Income Before Income Taxes and Equity in Net (Income) Loss of Equity-Method Investees
Income before income taxes and equity in the after tax earnings of our equity-method investees for the three months ended March 31, 2017 and 2016 was $39.6 million and $72.9 million, respectively. The decrease was due to the items discussed above.
34

Table of Contents
Provision for Income Taxes
The provision for income taxes includes federal, foreign, state and local income taxes and was $8.1 million for the three months ended March 31, 2017 compared to $23.9 million for the prior year quarter.
Our effective income tax rate from continuing operations was 20.4% and 32.8% of pre-tax income for the three months ended March 31, 2017 and 2016, respectively. The effective income tax rate for the three months ended March 31, 2017 was favorably impacted by the geographical mix of earnings and a reduction in the statutory tax rate in the United Kingdom enacted in the first quarter of fiscal 2017, which resulted in a $2.1 million decrease to the carrying value of net deferred tax liabilities. The effective tax rate for the three months ended March 31, 2017 was also favorably impacted by a $3.5 million benefit relating to the release of a portion of the Company’s uncertain tax positions as a result of the expiration of the statute of limitations.
Our effective tax rate may change from period to period based on recurring and non-recurring factors, including the geographical mix of earnings, enacted tax legislation, state and local income taxes and tax audit settlements.
Equity in Net (Income) Loss of Equity-Method Investees
Our equity in the net (income) loss from our equity-method investments for the three months ended March 31, 2017 and March 31, 2016 was essentially break-even. See Note 13, Investments and Joint Ventures, in the Notes to Consolidated Financial Statements included in Item 1 of this Form 10-Q.
Net Income
Net income for the three months ended March 31, 2017 and 2016 was $31.3 million and $48.8 million, or $0.30 and $0.47 per diluted share, respectively. The decrease was attributable to the factors noted above.
Adjusted EBITDA
Our Adjusted EBITDA was $74.7 million and $98.1 million for the three months ended March 31, 2017 and 2016, respectively, as a result of the factors discussed above. See Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures following the discussion of our results of operations for definitions and a reconciliation from our net income to Adjusted EBITDA.
35

Table of Contents
Segment Results
The following table provides a summary of net sales and operating income by reportable segment for the three months ended March 31, 2017 and 2016:

(dollars in thousands) |  | United States |  | United Kingdom |  | Hain Pure Protein |  | Rest of World |  | Corporate and Other |  | Consolidated
Net sales |  |  |  |  |  |  |  |  |  |  |  |
Three months ended 3/31/17 |  | $ | 308,539 |  |  | $ | 181,940 |  |  | $ | 117,765 |  |  | $ | 98,319 |  |  | $ | — |  |  | $ | 706,563 |
Three months ended 3/31/16 |  | 325,384 |  |  | 206,160 |  |  | 112,213 |  |  | 92,906 |  |  | — |  |  | 736,663 |
$ change |  | $ | (16,845 | ) |  | $ | (24,220 | ) |  | $ | 5,552 |  |  | $ | 5,413 |  |  | n/a |  |  | $ | (30,100 | )
% change |  | (5.2 | )% |  | (11.7 | )% |  | 4.9 | % |  | 5.8 | % |  | n/a |  |  | (4.1 | )%
Operating income |  |  |  |  |  |  |  |  |  |  |  |
Three months ended 3/31/17 |  | $ | 46,838 |  |  | $ | 11,545 |  |  | $ | (2,554 | ) |  | $ | 9,362 |  |  | $ | (18,124 | ) |  | $ | 47,067 |
Three months ended 3/31/16 |  | 56,381 |  |  | 15,826 |  |  | 2,427 |  |  | 8,132 |  |  | (11,618 | ) |  | 71,148 |
$ change |  | $ | (9,543 | ) |  | $ | (4,281 | ) |  | $ | (4,981 | ) |  | $ | 1,230 |  |  | $ | (6,506 | ) |  | $ | (24,081 | )
% change |  | (16.9 | )% |  | (27.1 | )% |  | (205.2 | )% |  | 15.1 | % |  | 56.0 | % |  | (33.8 | )%
Operating income margin |  |  |  |  |  |  |  |  |  |  |  |
Three months ended 3/31/17 |  | 15.2 | % |  | 6.3 | % |  | (2.2 | )% |  | 9.5 | % |  | n/a |  |  | 6.7 | %
Three months ended 3/31/16 |  | 17.3 | % |  | 7.7 | % |  | 2.2 | % |  | 8.8 | % |  | n/a |  |  | 9.7 | %

United States
Our net sales in the United States for the three months ended March 31, 2017 were $308.5 million, a decrease of $16.8 million, or 5.2%, from net sales of $325.4 million for the three months ended March 31, 2016. Foreign currency exchange rates decreased net sales by $3.0 million when compared to the prior year quarter due to the United Kingdom operations of Ella’s Kitchen, which is included in the United States segment. The sales decrease was primarily due to a realignment of customer inventories, the discontinuance of certain unprofitable SKUs as part of a product rationalization initiative implemented at the beginning of fiscal 2017 and competitive pricing actions on certain products. Net sales in the prior year quarter benefited from certain concessions provided to our largest distributors, including payment terms beyond the customer’s standard terms, rights of return of product and post-sale concessions, most of which were associated with sales that occurred at the end of the quarter. Operating income in the United States in the three months ended March 31, 2017 was $46.8 million, a decrease of $9.5 million from operating income of $56.4 million in the three months ended March 31, 2016. The decrease in operating income is the result of the aforementioned items, as well as incremental trade and marketing spend and unfavorable customer sales mix.
United Kingdom
Our net sales in the United Kingdom segment in the three months ended March 31, 2017 were $181.9 million, a decrease of $24.2 million, or 11.7%, from net sales of $206.2 million for the three months ended March 31, 2016. Foreign currency exchange rates decreased net sales by $26.7 million as compared to the prior year quarter. Operating income in the United Kingdom segment for the three months ended March 31, 2017 was $11.5 million, a decrease of $4.3 million, from $15.8 million for the three months ended March 31, 2016. The decrease in operating income was primarily due to increased production costs at Orchard House caused by lower quality fruit and insufficient crop yields due to unfavorable growing conditions.
Hain Pure Protein
Our net sales in the Hain Pure Protein segment for the three months ended March 31, 2017 were $117.8 million, an increase of $5.6 million, or 4.9%, from net sales of $112.2 million in the three months ended March 31, 2016. The increase was primarily due to the mix of products sold at HPPC and increased net sales volume at Empire due to the timing of the Passover holiday. The prior year period was favorably impacted by the one-time impact of a supply shortage within poultry farms in the Midwest, for which HPPC was not affected, which favorably impacted volume and pricing of turkey breast meat sales in the prior year period at HPPC and Empire. Operating income in the Hain Pure Protein segment for the three months ended March 31, 2017 was a loss
36

Table of Contents
of $2.6 million, a decrease of $5.0 million from income of $2.4 million for the three months ended March 31, 2016. The decrease in operating income was primarily due to production inefficiencies and increased start-up costs and production in connection with our new FreeBird manufacturing facility.
Rest of World
Our net sales in the Rest of World segment were $98.3 million for the three months ended March 31, 2017, an increase of $5.4 million, or 5.8%, from net sales of $92.9 million for the three months ended March 31, 2016. The increase was primarily the result of increased sales in Europe related to our our plant-based, private label beverage business as a result of our acquisition of Mona in the first quarter of fiscal 2016, as well as increased sales in Canada related to many of our products sold. This was partially offset by a decrease in net sales from the prior year quarter related to Cultivate. Operating income in the Rest of World segment for the three months ended March 31, 2017 was $9.4 million, an increase of $1.2 million, from $8.1 million for the three months ended March 31, 2016. The increase in operating income was primarily due to the aforementioned items above, as well as operating efficiencies achieved at our plant-based manufacturing facilities, offset by a decline in operating income related to Cultivate.
Corporate and Other
Our Corporate and Other category consists of expenses related to the Company’s centralized administrative function, which do not specifically relate to an operating segment. Such Corporate expenses are comprised mainly of the compensation and related expenses of certain of the Company’s senior executive officers and other employees who perform duties related to our entire enterprise, as well as expenses for certain professional fees, facilities and other items which benefit the Company as a whole. Additionally, accounting review costs and acquisition related expenses, restructuring and integration charges and other are included in Corporate and Other, which were $9.2 million and $5.3 million for the three months ended March 31, 2017 and 2016, respectively.
Refer to Note 16, Segment Information, in the Notes to Consolidated Financial Statements included in Item 1 of this Form 10-Q.
37

Table of Contents
Results of Operations
Comparison of Nine Months Ended March 31, 2017 to Nine Months Ended March 31, 2016
Consolidated Results
The following table compares our results of operations, including as a percentage of net sales, on a consolidated basis, for the nine months ended March 31, 2017 and 2016 (amounts in thousands, other than percentages which may not add due to rounding):

| Nine Months Ended |  | Change in
| March 31, 2017 |  | March 31, 2016 |  | Dollar |  | Percentage
Net sales | $ | 2,128,026 |  |  | 100.0% |  | $ | 2,147,827 |  |  | 100.0% |  | $ | (19,801 | ) |  | (0.9)%
Cost of sales | 1,736,373 |  |  | 81.6% |  | 1,683,777 |  |  | 78.4% |  | 52,596 |  |  | 3.1%
Gross profit | 391,653 |  |  | 18.4% |  | 464,050 |  |  | 21.6% |  | (72,397 | ) |  | (15.6)%
Selling, general and administrative expenses | 252,730 |  |  | 11.9% |  | 223,421 |  |  | 10.4% |  | 29,309 |  |  | 13.1%
Amortization of acquired intangibles | 13,964 |  |  | 0.7% |  | 13,896 |  |  | 0.6% |  | 68 |  |  | 0.5%
Acquisition related expenses, restructuring and integration charges and other | 2,652 |  |  | 0.1% |  | 11,235 |  |  | 0.5% |  | (8,583 | ) |  | (76.4)%
Accounting review costs | 20,089 |  |  | 0.9% |  | — |  |  | — |  | 20,089 |  |  | n/a
Operating income | 102,218 |  |  | 4.8% |  | 215,498 |  |  | 10.0% |  | (113,280 | ) |  | (52.6)%
Interest and other financing expense, net | 15,617 |  |  | 0.7% |  | 19,687 |  |  | 0.9% |  | (4,070 | ) |  | (20.7)%
Other (income)/expense, net | 207 |  |  | — |  | 8,844 |  |  | 0.4% |  | (8,637 | ) |  | (97.7)%
Gain on fire insurance recovery | — |  |  | — |  | (9,013 | ) |  | (0.4)% |  | 9,013 |  |  | (100.0)%
Income before income taxes and equity in net (income) of equity-method investees | 86,394 |  |  | 4.1% |  | 195,980 |  |  | 9.1% |  | (109,586 | ) |  | (55.9)%
Provision for income taxes | 19,322 |  |  | 0.9% |  | 59,846 |  |  | 2.8% |  | (40,524 | ) |  | (67.7)%
Equity in net (income) of equity-method investees | (45 | ) |  | — |  | 108 |  |  | — |  | (153 | ) |  | (141.7)%
Net income | $ | 67,117 |  |  | 3.2% |  | $ | 136,026 |  |  | 6.3% |  | $ | (68,909 | ) |  | (50.7)%
Adjusted EBITDA | $ | 189,828 |  |  | 8.9% |  | $ | 287,786 |  |  | 13.4% |  | $ | (97,958 | ) |  | (34.0)%

Net Sales
Net sales for the nine months ended March 31, 2017 were $2.13 billion, a decrease of $19.8 million, or 0.9%, from net sales of $2.15 billion for the nine months ended March 31, 2016. Foreign currency exchange rates resulted in decreased net sales of $96.2 million as compared to the prior year period. On a constant currency basis, net sales increased 3.6% from the prior year period. The increase in net sales on a constant currency basis resulted primarily from the acquisition of Orchard House in December 2015, which accounted for approximately $115.1 million of net sales for the nine months ended March 31, 2017, as compared to $39.7 million for the prior year period, offset in part by a realignment of customer inventories and SKU rationalizations in our United States segment, as well as increased trade spend and competitive pricing actions taken in all segments.
Gross Profit
Gross profit for the nine months ended March 31, 2017 was $391.7 million, a decrease of $72.4 million, or 15.6%, as compared to the prior year period. Foreign exchange rates resulted in decreased cost of goods sold of $78.6 million as compared to the prior year period. Gross profit margin was 18.4%, a decrease of 320 basis points from the prior year period. Gross profit was unfavorably impacted by price adjustments and customer sales mix in the United States, margin dilution from the acquisition of Orchard House, increased production costs in the United Kingdom, increased costs of purchases in non-functional currencies, and increased start-up costs in connection with our new FreeBird manufacturing facility at HPPC. Additionally, the prior year quarter was impacted by a supply shortage within poultry farms in the Midwest, which favorably impacted sales volume and pricing at HPPC. The decrease in gross profit was offset in part by increased sales and operating efficiencies at our plant-based manufacturing facilities in Europe.
38

Table of Contents
Selling, General and Administrative Expenses
Selling, general and administrative expenses were $252.7 million, an increase of $29.3 million, or 13%, in the nine months ended March 31, 2017 from $223.4 million for the prior year period. Selling, general and administrative expenses were favorably impacted in the prior year due to reduced incentive compensation, savings from headcount reductions and other benefit cost savings. Additionally, selling, general and administrative expenses increased as a result of additional marketing spend in the United States, and increased professional fees at Corporate and our Hain Pure Protein segment. Lastly, selling, general and administrative expenses increased as a result of our acquisition of Orchard House, which we acquired at the end of the second quarter in fiscal 2016, and incremental costs associated with the closure of our Luton manufacturing facility in the United Kingdom. Selling, general and administrative expenses as a percentage of net sales was 11.9% in the nine months ended March 31, 2017 and 10.4% in the prior year period, an increase of 150 basis points, primarily attributable to the aforementioned items.
Amortization of Acquired Intangibles
Amortization of acquired intangibles was $14.0 million, an increase of $0.1 million, for the nine months ended March 31, 2017 from $13.9 million for the prior year period. The increase was primarily due to the impact of foreign currency exchange rates, which favorably impacted amortization by $1.2 million, partially offset by amortization related to intangibles acquired as a result of the Company’s recent acquisitions. See Note 8, Goodwill and Other Intangible Assets, in the Notes to Consolidated Financial Statements included in Item 1 of this Form 10-Q.
Acquisition Related Expenses, Restructuring and Integration Charges and Other
Acquisition related expenses, restructuring and integration charges and other were $2.7 million for the nine months ended March 31, 2017, which primarily related to professional fees associated with the acquisitions of Orchard House in fiscal 2016 and The Yorkshire Provender in the United Kingdom, which closed in the fourth quarter of fiscal 2017, consulting fees incurred in connection with our execution of Project Terra and severance with respect to the United States and Corporate.
Acquisition related expenses, restructuring and integration charges and other were $11.2 million in the nine months ended March 31, 2016, which primarily related to the Orchard House and Mona acquisitions, severance costs for a recent internal restructuring, most of which occurred in the United States and, to a lesser extent, additional contingent consideration expense for Belvedere.
Accounting Review Costs
Accounting review costs were $20.1 million for the nine months ended March 31, 2017, which related to professional fees associated with our internal accounting review. See Explanatory Note on page 2 of this Form 10-Q and Note 3, Correction of Immaterial Errors to Prior Period Financial Statements, in the Notes to Consolidated Financial Statements included in Item 1 of this Form 10-Q for details.
Operating Income
Operating income for the nine months ended March 31, 2017 was $102.2 million, a decrease of $113.3 million, or 52.6%, from $215.5 million for the nine months ended March 31, 2016. Operating income as a percentage of net sales was 4.8% for the nine months ended March 31, 2017 compared with 10.0% for the comparable period of fiscal 2015. The decrease in operating income as a percentage of net sales resulted from the items described above.
Interest and Other Financing Expense, net
Interest and other financing expense, net totaled $15.6 million for the nine months ended March 31, 2017, a decrease of $4.1 million, or 21%, from $19.7 million for the prior year period. The decrease in interest and other financing expense, net resulted primarily from the conversion of our $150.0 million senior notes to our revolving credit facility in the fourth quarter of fiscal 2016. See Note 9, Debt and Borrowings, in the Notes to Consolidated Financial Statements included in Item 1 of this Form 10-Q.
Other (Income)/Expense, net
Other (Income)/Expense, net totaled $0.2 million of expense for the nine months ended March 31, 2017, an increase of $8.6 million, or 97.7% from $8.8 million of expense in the prior year period. Included in other (income)/expense, net are net unrealized foreign currency losses, which were lower in the current year period than the prior year period principally due to the effect of foreign currency movements on the remeasurement of foreign currency denominated intercompany loans.
39

Table of Contents
Income Before Income Taxes and Equity in Net (Income) of Equity-Method Investees
Income before income taxes and equity in the after tax earnings of our equity-method investees for the nine months ended March 31, 2017 and 2016 was $86.4 million and $196.0 million, respectively. The decrease was due to the items discussed above.
Provision for Income Taxes
The provision for income taxes includes federal, foreign, state and local income taxes and was $19.3 million for the nine months ended March 31, 2017 compared to $59.8 million for the prior year period.
Our effective income tax rate from continuing operations was 22.4% and 30.5% of pre-tax income for the nine months ended March 31, 2017 and 2016, respectively. The effective tax rate for the nine months ended March 31, 2017 was favorably impacted by the geographical mix of earnings and a reduction in the statutory tax rate in the United Kingdom enacted in the first quarter of fiscal 2017, which resulted in a $2.1 million decrease to the carrying value of net deferred tax liabilities. The effective tax rate for the nine months ended March 31, 2017 was also favorably impacted by a $3.5 million benefit relating to the release of a portion of the Company’s uncertain tax positions as a result of the expiration of the statute of limitations.
Our effective tax rate may change from period to period based on recurring and non-recurring factors, including the geographical mix of earnings, enacted tax legislation, state and local income taxes and tax audit settlements.
Equity in Net (Income) of Equity-Method Investees
Our equity in the net income from our equity-method investments for the nine months ended March 31, 2017 was $0.05 million compared to a loss of $0.1 million for the nine months ended March 31, 2016. See Note 13, Investments and Joint Ventures, in the Notes to Consolidated Financial Statements included in Item 1 of this Form 10-Q.
Net Income
Net income for the nine months ended March 31, 2017 and 2016 was $67.1 million and $136.0 million, or $0.64 and $1.31 per diluted share, respectively. The decrease was attributable to the factors noted above.
Adjusted EBITDA
Our Adjusted EBITDA was $189.8 million and $287.8 million in the nine months ended March 31, 2017 and 2016, respectively, as a result of the factors discussed above. See Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures following the discussion of our results of operations for definitions and a reconciliation from our net income to Adjusted EBITDA.
40

Table of Contents
Segment Results
The following table provides a summary of net sales and operating income by reportable segment for the nine months ended March 31, 2017 and 2016:

(dollars in thousands) |  | United States |  | United Kingdom |  | Hain Pure Protein |  | Rest of World |  | Corporate and Other |  | Consolidated
Net sales |  |  |  |  |  |  |  |  |  |  |  |
Nine months ended 3/31/17 |  | $ | 882,273 |  |  | $ | 573,541 |  |  | $ | 387,413 |  |  | $ | 284,799 |  |  | $ | — |  |  | $ | 2,128,026 |
Nine months ended 3/31/16 |  | 942,700 |  |  | 558,269 |  |  | 379,459 |  |  | 267,399 |  |  | — |  |  | 2,147,827 |
$ change |  | $ | (60,427 | ) |  | $ | 15,272 |  |  | $ | 7,954 |  |  | $ | 17,400 |  |  | n/a |  |  | $ | (19,801 | )
% change |  | (6.4 | )% |  | 2.7 | % |  | 2.1 | % |  | 6.5 | % |  | n/a |  |  | (0.9 | )%
Operating income |  |  |  |  |  |  |  |  |  |  |  |
Nine months ended 3/31/17 |  | $ | 111,453 |  |  | $ | 22,792 |  |  | $ | (31 | ) |  | $ | 21,894 |  |  | $ | (53,890 | ) |  | $ | 102,218 |
Nine months ended 3/31/16 |  | 148,828 |  |  | 44,093 |  |  | 31,078 |  |  | 17,646 |  |  | (26,147 | ) |  | 215,498 |
$ change |  | $ | (37,375 | ) |  | $ | (21,301 | ) |  | $ | (31,109 | ) |  | $ | 4,248 |  |  | $ | (27,743 | ) |  | $ | (113,280 | )
% change |  | (25.1 | )% |  | (48.3 | )% |  | (100.1 | )% |  | 24.1 | % |  | 106.1 | % |  | (52.6 | )%
Operating income margin |  |  |  |  |  |  |  |  |  |  |  |
Nine months ended 3/31/17 |  | 12.6 | % |  | 4.0 | % |  | — | % |  | 7.7 | % |  | n/a |  |  | 4.8 | %
Nine months ended 3/31/16 |  | 15.8 | % |  | 7.9 | % |  | 8.2 | % |  | 6.6 | % |  | n/a |  |  | 10.0 | %

United States
Our net sales in the United States for the nine months ended March 31, 2017 were $882.3 million, a decrease of $60.4 million, or 6.4%, from net sales of $942.7 million for the nine months ended March 31, 2016. Foreign currency changes decreased net sales by $11.1 million compared to the prior year period due to the United Kingdom operations of Ella’s Kitchen, which is included in the United States segment. The sales decrease was primarily due to a realignment of customer inventories, the discontinuance of certain unprofitable SKUs as part of a product rationalization initiative implemented at the beginning of fiscal 2017 and competitive pricing actions on certain products. Net sales in the prior year period benefited from certain concessions provided to our largest distributors, including payment terms beyond the customer’s standard terms, rights of return of product and post-sale concessions, most of which were associated with sales that occurred at the end of the period. Operating income in the United States for the nine months ended March 31, 2017 was $111.5 million, a decrease of $37.4 million from operating income of $148.8 million for the nine months ended March 31, 2016. The decrease in operating income is the result of the aforementioned items, as well as incremental trade and marketing spend and unfavorable customer sales mix.
United Kingdom
Our net sales in the United Kingdom segment for the nine months ended March 31, 2017 were $573.5 million, an increase of $15.3 million, or 2.7%, from net sales of $558.3 million for the nine months ended March 31, 2016. Foreign currency exchange rates resulted in decreased net sales by $84.4 million as compared to the prior year period. The increase in net sales was primarily driven by our recent acquisition of Orchard House in December 2015, which accounted for approximately $115.1 million of net sales in the current year period as compared to $39.7 million in the prior year period. Additionally, net sales increased due to strong sales performance within the plant-based and private label grocery categories, offset by the sale of our own-label juice business in the first quarter of fiscal 2017. Operating income in the United Kingdom segment for the nine months ended March 31, 2017 was $22.8 million, a decrease of $21.3 million, from $44.1 million in the nine months ended March 31, 2016. The decrease in operating income was primarily due to the aforementioned items, offset by the adverse impact of foreign currency on certain raw materials costs and increased production costs caused by lower quality fruit due to unfavorable growing conditions and insufficient crop yields at Orchard House.
41

Table of Contents
Hain Pure Protein
Our net sales in the Hain Pure Protein segment for the nine months ended March 31, 2017 were $387.4 million, an increase of $8.0 million, or 2.1%, from net sales of $379.5 million for the nine months ended March 31, 2016. The increase in net sales was primarily due to the mix of products sold, offset in part by price declines at HPPC as a result of our competitors recovering from a supply shortage within poultry farms in the Midwest, for which HPPC was not affected, which favorably impacted volume and pricing of turkey breast meat sales at HPPC and Empire in the prior year period, as well as supply disruptions and production constraints at our turkey manufacturing facility at HPPC. Operating income in the segment for the nine months ended March 31, 2017 was break-even, compared with $31.1 million for the nine months ended March 31, 2016. The decrease in operating income was primarily due to production inefficiencies and increased start-up costs and production in connection with our new FreeBird manufacturing facility.
Rest of World
Our net sales in the Rest of World segment were $284.8 million for the nine months ended March 31, 2017, an increase of $17.4 million, or 6.5%, from net sales of $267.4 million for the nine months ended March 31, 2016. Foreign currency exchange rates resulted in decreased net sales by $0.7 million as compared to the prior year period. The increase in net sales was primarily the result of increased sales in Europe related to our plant-based, private label beverage business as a result of our acquisition of Mona in the first quarter of fiscal 2016, as well as strong growth across many of our brands in Europe and Canada. This increase was partially offset by a decrease in net sales from the prior year period related to Cultivate. Operating income in the Rest of World segment for the nine months ended March 31, 2017 was $21.9 million, an increase of $4.2 million, from $17.6 million for the nine months ended March 31, 2016. Operating income increased primarily due to the aforementioned items above, as well as operating efficiencies achieved at our plant-based manufacturing facilities in Europe, offset by a decline in operating income related to Cultivate.
Corporate and Other
Our Corporate and Other category consists of expenses related to the Company’s centralized administrative function which do not specifically relate to an operating segment. Such Corporate expenses are comprised mainly of the compensation and related expenses of certain of the Company’s senior executive officers and other employees who perform duties related to our entire enterprise, as well as expenses for certain professional fees, facilities and other items which benefit the Company as a whole. Additionally, accounting review costs and acquisition related expenses, restructuring and integration charges and other are included in Corporate and Other, which were $22.7 million and $9.9 million for the nine months ended March 31, 2017 and 2016, respectively.
Refer to Note 16, Segment Information, in the Notes to Consolidated Financial Statements included in Item 1 of this Form 10-Q.
Liquidity and Capital Resources
We finance our operations and growth primarily with the cash flows we generate from our operations and from borrowings available to us under our credit agreement.
Our cash and cash equivalents balance was $162.6 million at March 31, 2017, an increase of $34.7 million when compared to $127.9 million at June 30, 2016. Our working capital was $558.4 million at March 31, 2017, an increase of $15.2 million from $543.2 million at the end of fiscal 2016.
Liquidity is affected by many factors, some of which are based on normal ongoing operations of the Company’s business and some of which arise from fluctuations related to global economics and markets. The Company’s cash balances are held in the United States, the United Kingdom, Canada, Europe and India. It is the Company’s current intent to indefinitely reinvest its foreign earnings outside the United States. As of March 31, 2017, approximately 63% ($102.8 million) of our total cash balance was held outside of the United States. Although a significant portion of the consolidated cash balances are maintained outside of the United States, the Company’s current plans do not demonstrate a need to repatriate these balances to fund its United States operations. If these funds were to be needed for the Company’s operations in the United States, it may be required to record and pay significant United States income taxes to repatriate these funds.
42

Table of Contents
We maintain our cash and cash equivalents primarily in money market funds or their equivalent. As of March 31, 2017, all of our investments were expected to mature in less than three months. Accordingly, we do not believe that our investments have significant exposure to interest rate risk. Cash provided by (used in) operating, investing and financing activities is summarized below.

| Nine Months Ended March 31, |  | Change in
(amounts in thousands) | 2017 |  | 2016 |  | Dollars |  | Percentage
Cash flows provided by (used in): |  |  |  |  |  |  |
Operating activities | $ | 147,952 |  |  | $ | 131,854 |  |  | $ | 16,098 |  |  | 12.2 | %
Investing activities | (37,645 | ) |  | (215,083 | ) |  | 177,438 |  |  | (82.5 | )%
Financing activities | (70,741 | ) |  | 47,623 |  |  | (118,364 | ) |  | (248.5 | )%
Effect of exchange rate changes on cash | (4,850 | ) |  | (5,926 | ) |  | 1,076 |  |  | (18.2 | )%
Net increase (decrease) in cash | $ | 34,716 |  |  | $ | (41,532 | ) |  | $ | 76,248 |  |  | (183.6 | )%

Cash provided by operating activities was $148.0 million for the nine months ended March 31, 2017, an increase of $16.1 million from the $131.9 million of cash provided by operating activities in the nine months ended March 31, 2016. This increase resulted primarily from $82.3 million of less cash used within working capital accounts, partially offset by a decrease of $66.2 million in net income adjusted for non-cash charges.
Cash used in investing activities was $37.6 million for the nine months ended March 31, 2017, a decrease of $177.4 million from the $215.1 million of cash used in investing activities for the nine months ended March 31, 2016. The decrease resulted primarily from $157.1 million of payments for the acquisitions of Mona and Orchard House, net of cash acquired and working capital settlements, as well as our investment in Chop’t, all of which occurred during the first half of fiscal 2016. There were no acquisitions completed in the nine months ended March 31, 2017. Additionally, there was a decrease of $14.0 million in capital expenditures during the nine months ended March 31, 2017 compared to the same period of fiscal 2016. This decrease related to the purchase of a new factory location and production equipment at HPPC in fiscal 2016. There were no similar purchases made during the nine months ended March 31, 2017.
Cash used in financing activities was $70.7 million for the nine months ended March 31, 2017, a decrease of $118.4 million from the $47.6 million of net cash provided by financing activities for the nine months ended March 31, 2016. This decrease resulted primarily from net repayments on our revolving credit facility and other debt of $63.6 million during the first nine months of fiscal 2017 compared to net new borrowings under our Credit Agreement and other debt of $61.5 million during the same period of 2016. The borrowings during the nine months ended March 31, 2016 were primarily used to fund the acquisitions of Orchard House and Mona. This $125.1 million decrease in net new borrowings was partially offset by $8.0 million of decreased excess tax benefits on stock-based compensation in the first nine months March 2017 when compared to the same period of the prior year.
Operating Free Cash Flow
Our operating free cash flow was $103.9 million for the nine months ended March 31, 2017, an increase of $30.1 million from the nine months ended March 31, 2016. This increase resulted primarily from $82.3 million of less cash used within working capital accounts, partially offset by a decrease of $66.2 million in net income adjusted for non-cash charges. We expect that our capital spending for the current fiscal year will be approximately $70 million. We refer the reader to the Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures following the discussion of our results of operations for definitions and a reconciliation from our net cash provided by operating activities to operating free cash flow.
Credit Agreement
On December 12, 2014, we entered into the Second Amended and Restated Credit Agreement (the “Credit Agreement”) which provides us with a $1.0 billion revolving credit facility which may be increased by an additional uncommitted $350.0 million provided certain conditions are met. The Credit Agreement expires in December 2019. Loans under the Credit Agreement bear interest at a Base Rate or a Eurocurrency Rate (both of which are defined in the Credit Agreement) plus an applicable margin, which is determined in accordance with a leverage-based pricing grid, as set forth in the Credit Agreement. Borrowings may be used to provide working capital, finance capital expenditures and permitted acquisitions, refinance certain existing indebtedness and for other general corporate purposes. As of March 31, 2017 and June 30, 2016, there were $774.4 million and $827.9 million of borrowings outstanding, respectively, under the Credit Agreement.
43

Table of Contents
The Credit Agreement is guaranteed by substantially all of our current and future direct and indirect domestic subsidiaries. We are required by the terms of the Credit Agreement to comply with financial and other customary affirmative and negative covenants for facilities of this nature. As of March 31, 2017 and June 30, 2016, the Company was deemed to be in compliance with all associated covenants due to certain limited waivers and extensions received by the Company in connection with its obligation to deliver financial information.
Tilda Short-Term Borrowing Arrangements
Tilda maintains short-term borrowing arrangements primarily used to fund the purchase of rice from India and other countries. The maximum borrowings permitted under all such arrangements are £52.0 million. Outstanding borrowings are secured by the current assets of Tilda, typically have six-month terms, and bear interest at variable rates typically based on LIBOR plus a margin (weighted average interest rate of approximately 2.8% at March 31, 2017).
Other Borrowings
Other borrowings primarily relate to a cash pool facility in Europe. The cash pool facility provides our Europe operating segment with sufficient liquidity to support the Company’s growth objectives within this segment. The maximum borrowings permitted under the cash pool arrangement are €12.5 million. Outstanding borrowings bear interest at variable rates typically based on EURIBOR plus a margin of 1.1% (weighted average interest rate of approximately 1.1% at March 31, 2017).
We believe that our cash on hand of $162.6 million at March 31, 2017, as well as projected cash flows from operations and availability under our Credit Agreement, are sufficient to fund our working capital needs in the ordinary course of business, anticipated fiscal 2017 capital expenditures of approximately $70 million, and the other expected cash requirements for at least the next twelve months.
Share-Repurchase Program
On June 21, 2017, the Company's Board of Directors authorized the repurchase of up to $250 million of the Company’s issued and outstanding common stock. The extent to which the Company repurchases its shares and the timing of such repurchases will depend upon market conditions and other corporate considerations including the Company’s historical strategy of pursuing accretive acquisitions.
Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures
We have included in this report measures of financial performance that are not defined by U.S. GAAP. We believe that these measures provide useful information to investors, and include these measures in other communications to investors.
For each of these non-U.S. GAAP financial measures, we are providing below a reconciliation of the differences between the non-U.S. GAAP measure and the most directly comparable U.S. GAAP measure, an explanation of why our management and Board of Directors believes the non-U.S. GAAP measure provides useful information to investors and any additional purposes for which our management and Board of Directors uses the non-U.S. GAAP measure. These non-U.S. GAAP measures should be viewed in addition to, and not in lieu of, the comparable U.S. GAAP measure.
Constant Currency Presentation
We believe that this measure provides useful information to investors because it provides transparency to underlying performance in our consolidated net sales by excluding the effect that foreign currency exchange rate fluctuations have on year-to-year comparability given the volatility in foreign currency exchange markets. To present this information for historical periods, current period net sales for entities reporting in currencies other than the U.S. dollar are translated into U.S. dollars at the average monthly exchange rates in effect during the corresponding period of the prior fiscal year, rather than at the actual average monthly exchange rate in effect during the current period of the current fiscal year. As a result, the foreign currency impact is equal to the current year results in local currencies multiplied by the change in average foreign currency exchange rate between the current fiscal period and the corresponding period of the prior fiscal year.
44

Table of Contents
A reconciliation between reported and constant currency sales growth is as follows:

(amounts in thousands) | Three Months Ended March 31, 2017 |  | Nine Months Ended March 31, 2017
Change in consolidated net sales | $ | (30,100 | ) |  | (4.1 | )% |  | $ | (19,801 | ) |  | (0.9 | )%
Impact of foreign currency exchange | 29,907 |  |  | 4.1 | % |  | 96,150 |  |  | 4.5 | %
Change in consolidated net sales on a constant-currency basis | $ | (193 | ) |  | — | % |  | $ | 76,349 |  |  | 3.6 | %

Adjusted EBITDA
Adjusted EBITDA is defined as net income before income taxes, net interest expense, depreciation and amortization, impairment of long lived assets, equity in the earnings of equity-method investees, stock based compensation, acquisition-related expenses, including integration and restructuring charges and other non-recurring items. The Company’s management believes that this presentation provides useful information to management, analysts and investors regarding certain additional financial and business trends relating to its results of operations and financial condition. In addition, management uses this measure for reviewing the financial results of the Company and as a component of performance-based executive compensation. Adjusted EBITDA is a Non-U.S. GAAP measure and may not be comparable to similarly titled measures reported by other companies.
We do not consider Adjusted EBITDA in isolation or as an alternative to financial measures determined in accordance with U.S. GAAP. The principal limitation of Adjusted EBITDA is that it excludes certain expenses and income that are required by U.S. GAAP to be recorded in our consolidated financial statements. In addition, Adjusted EBITDA is subject to inherent limitations as this metric reflects the exercise of judgment by management about which expenses and income are excluded or included in determining Adjusted EBITDA. In order to compensate for these limitations, management presents Adjusted EBITDA in connection with U.S. GAAP results.
45

Table of Contents
A reconciliation of net income to Adjusted EBITDA is as follows:

| Three Months Ended March 31, |  | Nine Months Ended March 31,
(amounts in thousands) | 2017 |  | 2016 |  | 2017 |  | 2016
Net income | $ | 31,328 |  |  | $ | 48,788 |  |  | $ | 67,117 |  |  | $ | 136,026 |
Income taxes | 8,051 |  |  | 23,914 |  |  | 19,322 |  |  | 59,846 |
Interest expense, net | 4,743 |  |  | 6,233 |  |  | 13,523 |  |  | 17,365 |
Depreciation and amortization | 17,131 |  |  | 16,309 |  |  | 51,299 |  |  | 48,099 |
Equity in earnings of equity-method investees | 177 |  |  | 161 |  |  | (45 | ) |  | 108 |
Stock-based compensation | 2,284 |  |  | 2,776 |  |  | 7,519 |  |  | 10,005 |
Unrealized currency gains and losses | 1,791 |  |  | (136 | ) |  | (1,486 | ) |  | 7,090 |
EBITDA | 65,505 |  |  | 98,045 |  |  | 157,249 |  |  | 278,539 |
Acquisition related fees and expenses, integration and restructuring charges and other | 2,083 |  |  | 3,806 |  |  | 3,599 |  |  | 10,239 |
Contingent consideration expense, net | — |  |  | 1,511 |  |  | — |  |  | 1,511 |
HPPC production interruption related to chiller breakdown and factory start-up costs | — |  |  | 3,054 |  |  | — |  |  | 4,111 |
Inventory costs for products discontinued or with redesigned packaging | — |  |  | — |  |  | 5,360 |  |  | — |
UK deferred synergies due to CMA board decision | — |  |  | — |  |  | 918 |  |  | — |
UK factory start-up costs | — |  |  | — |  |  | — |  |  | 743 |
US warehouse consolidation project | — |  |  | — |  |  | — |  |  | 426 |
Celestial Seasonings marketing support related to new packaging launch and Keurig transition | — |  |  | 700 |  |  | — |  |  | 1,000 |
Accounting review costs | 7,124 |  |  | — |  |  | 20,089 |  |  | — |
Recall and other related costs | — |  |  | — |  |  | 809 |  |  | — |
Tilda fire insurance recovery costs and other start-up/integration costs | — |  |  | — |  |  | — |  |  | 230 |
Gain on Tilda fire related fixed asset | — |  |  | (9,013 | ) |  | — |  |  | (9,013 | )
Luton closure costs | — |  |  | — |  |  | 1,804 |  |  | — |
Adjusted EBITDA | 74,712 |  |  | 98,103 |  |  | 189,828 |  |  | 287,786 |

Operating Free Cash Flow
In our internal evaluations, we use the non-U.S. GAAP financial measure “operating free cash flow.” The difference between operating free cash flow and cash flow provided by operating activities, which is the most comparable U.S. GAAP financial measure, is that operating free cash flow reflects the impact of capital expenditures. Since capital spending is essential to maintaining our operational capabilities, we believe that it is a recurring and necessary use of cash. As such, we believe investors should also consider capital spending when evaluating our cash provided by operating activities. We view operating free cash flow as an important measure because it is one factor in evaluating the amount of cash available for discretionary investments. We do not consider operating free cash flow in isolation or as an alternative to financial measures determined in accordance with U.S. GAAP.
A reconciliation from Cash flow provided by operating activities to operating free cash flow is as follows:

| Nine Months Ended March 31,
(amounts in thousands) | 2017 |  | 2016
Cash flow provided by operating activities | $ | 147,952 |  |  | $ | 131,854 |
Purchase of property, plant and equipment | (44,064 | ) |  | (58,022 | )
Operating free cash flow | $ | 103,888 |  |  | $ | 73,832 |

46

Table of Contents
Off Balance Sheet Arrangements
At March 31, 2017, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4) of Regulation S-K that have had, or are likely to have, a material current or future effect on our consolidated financial statements.
Critical Accounting Estimates
Our financial statements are prepared in accordance with accounting principles generally accepted in the United States. The accounting principles we use require us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and amounts of income and expenses during the reporting periods presented. We believe in the quality and reasonableness of our critical accounting policies; however, materially different amounts may be reported under different conditions or using assumptions different from those that we have applied. The accounting policies that have been identified as critical to our business operations and understanding the results of our operations pertain to revenue recognition, trade promotions and sales incentives, valuation of accounts and chargebacks receivable, accounting for acquisitions, valuation of long-lived assets, goodwill and intangible assets, stock based compensation, and valuation allowances for deferred tax assets. The application of each of these critical accounting policies and estimates is discussed in Item 7 of our Annual Report on Form 10-K for the fiscal year ended June 30, 2016.
Recent Accounting Pronouncements
Refer to Note 3, Summary of Significant Accounting Policies and Practices, in the Notes to the Consolidated Financial Statements as of June 30, 2016 and for the fiscal year then ended included in the Company’s Annual Report on Form 10-K for a detailed discussion on recently issued accounting pronouncements not yet adopted by the Company. There has been no change to the statements made in the Form 10-K as of the date of filing of this Form 10-Q.
Seasonality
Certain of our product lines have seasonal fluctuations. Hot tea, baking products, hot cereal, hot-eating desserts and soup sales are stronger in colder months, while sales of snack foods, sunscreen and certain of our prepared food and personal care products are stronger in the warmer months. Additionally, with our acquisitions of HPPC, Empire and Tilda, our net sales and earnings may further fluctuate based on the timing of holidays throughout the year. As such, our results of operations and our cash flows for any particular quarter are not indicative of the results we expect for the full year, and our historical seasonality may not be indicative of future quarterly results of operations. In recent years, net sales and diluted earnings per share in the first fiscal quarter have typically been the lowest of our four quarters.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
There have been no significant changes in market risk for the three and nine months ended March 31, 2017 from those addressed in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2016. See the information set forth in Part II, Item 7A, Quantitative and Qualitative Disclosures About Market Risk, of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2016.
Item 4. Controls and Procedures
Our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), with the assistance of other members of management, have reviewed the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Our
disclosure controls and procedures are intended to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is (1) recorded, processed, summarized and reported, within the time periods specified in the Security and Exchange Commission’s rules and forms and (2) accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure. Based on this review, our CEO and CFO have concluded that the disclosure controls and procedures were not effective as of March 31, 2017 due to material weaknesses in internal control over financial reporting discussed below.

• | Ineffective Control Environment - The Company’s control environment did not sufficiently promote effective internal control over financial reporting, which contributed to the other material weaknesses described below. Principal contributing factors included: (i) an insufficient number of personnel appropriately qualified to perform control design, execution and monitoring activities; (ii) an insufficient number of personnel with an appropriate level of U.S. GAAP knowledge and experience and ongoing training in the application of U.S. GAAP commensurate with our financial reporting requirements; and (iii) in certain instances, insufficient documentation or basis to support accounting estimates.

• | Revenue Recognition - The Company’s internal controls to identify, accumulate and assess the accounting impact of certain concessions or side agreements were not adequately designed or operating effectively to determine whether the Company’s revenue recognition criteria had been met. Specifically, the Company’s controls were not effective to ensure (i) consistent standards in the level of documentation of agreements required to support accurate recording of revenue transactions and (ii) that such documentation is retained, completed and independently reviewed to confirm certain terms impacting revenue recognition were accurately reflected in the Company’s books and records. In addition, the Company did not design and maintain effective controls over the timing and classification of trade promotion spending.

Remediation of the Material Weaknesses in Internal Control over Financial Reporting
Management is committed to the planning and implementation of remediation efforts to address the material weaknesses. These remediation efforts, summarized below, which have been implemented or are in process of implementation, are intended to both address the identified material weaknesses and to enhance our overall financial control environment. In this regard, our initiatives include:

• | The Company has created a new position, Global Revenue Controller, which has recently been filled. This Revenue Controller has the requisite knowledge and expertise in specific revenue recognition accounting rules. This Revenue Controller will be responsible for all aspects of the Company's revenue recognition policies, procedures and the proper application of accounting to the Company’s sales arrangements.

• | The Company has hired a new Controller of the Company’s United States segment who has the requisite knowledge and expertise required for this position. The United States Controller will be responsible for all accounting functions in the United States segment.

• | The Company has developed a comprehensive review process and monitoring controls over contracts with customers, customer payments and incentives, including corporate review of related accruals and presentation of trade promotions and incentives.

• | The Company has developed a comprehensive revenue recognition and contract review training program. This training is focused on senior-level management, customer-facing employees, as well as finance, sales and marketing personnel.

• | The Company has established an internal audit department that will report directly to the Audit Committee.

• | The Company will implement a Global Contract Management System to provide a central repository for contracts and to ensure proper level of review of contracts.

• | The Company has and will continue to enhance its organizational structure over all finance functions and increase the number of accounting personnel with knowledge, experience and training in U.S. GAAP to ensure that a formalized process for determining, documenting, communicating, implementing and monitoring controls over the period-end financial close and reporting processes is maintained.

• | While this remediation plan is being executed, the Company has also engaged additional external resources to support and supplement the Company's existing internal resources.

47

Table of Contents
When fully implemented and operational, we believe the measures described above will remediate the material weaknesses we have identified and strengthen our internal control over financial reporting. We are committed to continuing to improve our internal control processes and will continue to diligently and vigorously review our financial reporting controls and procedures. As we continue to evaluate and work to improve our internal control over financial reporting, our management may determine to take additional measures.
Changes in Internal Controls Over Financial Reporting
Other than the ongoing remediation efforts described above, there was no change in internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
48

Table of Contents
PART II - OTHER INFORMATION
Item 1. Legal Proceedings
Securities Class Actions Filed in Federal Court
On August 17, 2016, three securities class action complaints were filed in the Eastern District of New York against the Company alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The three complaints are: (1) Flora v. The Hain Celestial Group, Inc., et al., (the “Flora Complaint”); (2) Lynn v. the Hain Celestial Group, Inc., et al. (the “Lynn Complaint”); and (3) Spadola v. The Hain Celestial Group, Inc., et al. (the “Spadola Complaint” and, together with the Flora and Lynn Complaints, the “Securities Complaints”). The Securities Complaints allege that the Company and certain of its officers made materially false and misleading statements in press releases and SEC filings regarding the Company’s business, prospects and financial results. The Securities Complaints were brought on behalf of all persons who purchased or otherwise acquired Hain securities between November 5, 2015 and August 15, 2016. On October 17, 2016, six potential plaintiffs and their respective law firms moved to serve as lead plaintiff and counsel. On June 5, 2017, the Court issued an order for consolidation, appointment of Co-Lead Plaintiffs and approval of selection of co-lead counsel. Pursuant to this order, the Securities Complaints were consolidated under the caption In re The Hain Celestial Group, Inc. Securities Litigation, and Rosewood Funeral Home and Salamon Gimpel were appointed as Co-Lead Plaintiffs.
Stockholder Derivative Complaints Filed in State Court
On September 16, 2016, a stockholder derivative complaint, Paperny v. Heyer, et al. (the “Paperny Complaint”), was filed in New York State Supreme Court in Nassau County against the Board of Directors and certain officers of the Company alleging breach of fiduciary duty, unjust enrichment, lack of oversight and corporate waste. On December 2, 2016 and December 29, 2016, two additional stockholder derivative complaints were filed in New York State Supreme Court in Nassau County against the Board of Directors and certain officers under the captions Scarola v. Simon (the “Scarola Complaint”) and Shakir v. Simon (the “Shakir Complaint” and, together with the Paperny Complaint and the Scarola Complaint, the “Derivative Complaints”), respectively. Both the Scarola Complaint and the Shakir Complaint allege breach of fiduciary duty, lack of oversight and unjust enrichment. On February 16, 2017, the parties for the Derivative Complaints entered into a stipulation consolidating the matters under the caption In re The Hain Celestial Group (the “Consolidated Derivative Action”) in New York State Supreme Court in Nassau County, and the parties agreed to stay the Consolidated Derivative Action until November 2, 2017.
Additional Stockholder Class Action and Derivative Complaints Filed in Federal Court
On April 19, 2017 and April 26, 2017, two class action and stockholder derivative complaints were filed in the Eastern District of New York against the Board of Directors and certain officers of the Company under the captions Silva v. Simon, et al. (the “Silva Complaint”) and Barnes v. Simon, et al. (the “Barnes Complaint”), respectively. Both the Silva Complaint and the Barnes Complaint allege violation of securities law, breach of fiduciary duty, waste of corporate assets and unjust enrichment.
On May 23, 2017, an additional stockholder filed a complaint under seal in the Eastern District of New York against the Board of Directors and certain officers of the Company. The complaint alleges that the Company’s directors and certain officers made materially false and misleading statements in press releases and SEC filings regarding the Company’s business, prospects and financial results. The complaint also alleges that the Company violated its by-laws and Delaware law by failing to hold an Annual Stockholders Meeting and includes claims for breach of fiduciary duty, unjust enrichment and corporate waste.
SEC Investigation
As previously disclosed, the Company voluntarily contacted the SEC in August 2016 to advise it of the Company’s delay in the filing of its periodic reports and the performance of the independent review conducted by the Audit Committee. The Company has continued to provide information to the SEC on an ongoing basis, including, among other things, the results of the independent review of the Audit Committee as well as other information pertaining to its internal accounting review relating to revenue recognition. On January 31, 2017, the SEC issued a subpoena to the Company seeking documents relevant to its investigation. The Company is in the process of responding to the SEC’s requests for information and intends to cooperate fully with the SEC.
Other
In addition to the litigation described above, the Company is and may be a defendant in lawsuits from time to time in the normal course of business. While the results of litigation and claims cannot be predicted with certainty, the Company believes the reasonably possible losses of such matters, individually and in the aggregate, are not material. Additionally, the Company believes the probable
49

Table of Contents
final outcome of such matters will not have a material adverse effect on the Company’s consolidated results of operations, financial position, cash flows or liquidity.
Item 1A. Risk Factors
We have disclosed the risk factors affecting our business, results of operations and financial condition in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended June 30, 2016, filed with the SEC on June 22, 2017. There have been no material changes from the risk factors previously disclosed.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
The table below sets forth information regarding repurchases by the Company of its common stock during the periods indicated.

Period | (a) Total number of shares purchased (1) |  | (b) Average price paid per share |  | (c) Total number of shares purchased as part of publicly announced plans |  | (d) Maximum number of shares that may yet be purchased under the plans
January 1, 2017 - January 31, 2017 | 62 |  |  | $ | 40.02 |  |  | — |  |  | — |
February 1, 2017 - February 28, 2017 | 50 |  |  | 38.53 |  |  | — |  |  | — |
March 1, 2017 - March 31, 2017 | 892 |  |  | 37.20 |  |  | — |  |  | — |
Total | 1,004 |  |  | $ | 37.44 |  |  | — |  |  | — |

(1) | Shares surrendered for payment of employee payroll taxes due on shares issued under stockholder approved stock based compensation plans.

Item 6. Exhibits
See Exhibit Index immediately following the signature page hereto, which is incorporated herein by reference.
50

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

|  | THE HAIN CELESTIAL GROUP, INC.
|  | (Registrant)
Date: | June 22, 2017 | /s/ Irwin D. Simon
|  | Irwin D. Simon, Chairman, President and Chief Executive Officer

Date: | June 22, 2017 | /s/ Pasquale Conte
|  | Pasquale Conte, Executive Vice President and Chief Financial Officer

51

Table of Contents
EXHIBIT INDEX

Exhibit Number |  | Description
3.1 |  | Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 of Amendment No. 1 to the Company’s Registration Statement on Form S-4 (Commission File No. 333-33830) filed with the Commission on April 24, 2000).
3.2 |  | Certificate of Amendment to Amended and Restated Certificate of Incorporation of The Hain Celestial Group, Inc. (incorporated by reference to Exhibit 3.2(b) of the Company’s Current Report on Form 8-K filed with the Commission on November 26, 2014).
3.3 |  | The Hain Celestial Group, Inc. Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2(a) of the Company’s Current Report on Form 8-K filed with the Commission on November 26, 2014).
10.1 |  | Third Limited Waiver and Extension, dated February 27, 2017, to the Second Amended and Restated Credit Agreement, dated as of December 12, 2014, by and among The Hain Celestial Group, Inc., Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, Bank of America Merrill Lynch International Limited, as Global Swingline Lender, Wells Fargo Bank, N.A., as Syndication Agent, JPMorgan Chase Bank, N.A., Citizens Bank, N.A. and Farm Credit East, ACA, as Documentation Agents, and the other lenders party thereto (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the Commission on March 3, 2017).
31.1 |  | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended.
31.2 |  | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended.
32.1 |  | Certification by CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2 |  | Certification by CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101 |  | The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2017, formatted in eXtensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Income, (iii) the Condensed Consolidated Statements of Comprehensive Income, (iv) the Condensed Consolidated Statement of Stockholders’ Equity, (v) the Condensed Consolidated Statements of Cash Flows, and (vi) Notes to Condensed Consolidated Financial Statements.

The agreements and other documents filed as exhibits to this report are not intended to provide factual information or other disclosure other than with respect to the terms of the agreements or other documents themselves, and you should not rely on them for that purpose. In particular, any representations and warranties made by us in these agreements or other documents were made solely within the specific context of the relevant agreement or document and may not describe the actual state of affairs as of the date they were made or at any other time.
52